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ABSTRACT
THE ASSOCIATION OF THE HUMAN
CYTOMEGALOVIRUS GENOME
WITH THE CELLULAR NUCLEAR MATRIX

by

Brent Arnold
The regulatory region of the major immediate early gene (MIE)
of the human cytomegalovirus (HCMV) has been analyzed for its
capability of fulfilling criteria defining nuclear scaffold/matrix
attachment regions (S/MARs). These criteria are: 1) binding the
nuclear matrix in an in vitro nuclear matrix binding assay; 2) binding
the nuclear scaffold in an in situ nuclear scaffold binding assay; and
3) activating transcription of reporter genes in stabile transformed
cells.
The MIE gene was cloned, digested with restriction
endonucleases, and the resulting DNA fragments were reacted with
nuclear matrices prepared in vitro. Relative to coding region and
vector fragments, the regulatory region of the MIE gene bound the in
vitro nuclear matrix with the greatest affinity.
HCMV infected fibroblast nuclei were extracted with lithium
diiodosalycilate and digested with restriction endonucleases at
immediate early and early times post infection. Relative to >90% of
the total cellular DNA, the MIE regulatory region bound the in situ
nuclear scaffold at both times post infection. In addition, other
regions of the viral genome bound the in situ nuclear scaffold at
these times post infection.
A reporter gene construct driven by the full length MIE
regulatory region and a construct from which an upstream portion of
regulatory region was deleted, were separately co-transfected with

a neomycin resistance gene into human leukemic monocytes. Stabile
transformed cellular clones were selected by culturing the cells in
the presence of G418. The reporter gene activity from the full
length construct was 4-fold greater than the reporter gene activity
of the deleted construct.
This is the first study to show that a portion of the 5'
regulatory region of the MIE gene fulfills these criteria of S/MARs.
It is also the first to show the HCMV genome associates with the
nuclear scaffold in the infected cell nucleus.
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INTRODUCTION
An overwhelming amount of progress has been made over the
last 100 years in identifying the structural and functional
relationships which occur within the eukaryotic nucleus. A
milestone in this field occurred with the determination of the
nuclear matrix as an underlying structure providing the nucleus with
a fundamental architecture. Numerous models regarding the role of
the nuclear matrix in organizing and coordinating the genome and
nuclear metabolism have since been envisioned. It is now known the
nuclear matrix is a vital element of higher order chromatin
structure and is directly involved in such disparate nuclear
functions as replication, transcription, and RNA processing.
The nucleus was first studied in detail in the late 19th and
early 20th centuries using light microscopy techniques. These
studies revealed three main nuclear structural components: 1) the
chromatin; 2) the nucleolus; and 3) the nucleoplasm, which was also
called the nuclear sap, or karyolymph. Because of its transparent
appearance the nucleoplasm was believed to be a clear fluid or gel
into which the chromatin and nucleolus were suspended.
Biochemical fractionation of the nucleus using salts and detergents
as extracting agents showed that a subtraction of nuclear proteins
resisted solubilization in high ionic strength solutions (Mayer and
Gulick,1942; Mirsky and Ris,1947). The first electron microscopic
study of residual nuclei following extraction revealed structures
composed of a nuclear membrane, a residual nucleolus, and a sponge
like intranuclear network connecting the two (Braun and Ernst,
1960). Other electron microscopy studies of nuclei which were
extracted with 2 M NaCI revealed heterogeneous structures,
individual granules and fibers, in the interchromatinic and nonnucleolar regions (Zbarsky et al., 1962; Smetanna et al., 1963). This
led to a change in the concept of the nucleoplasm from that of a
homogeneous substance to that of a nuclear matrix or nuclear ground
substance (Fawcett, 1966). Thin section electron microscopy of
nuclei showed the nuclear ground substance actually contained two
3
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main structural components: the diffuse euchromatin, and the
nonchromatin granules and fibers of the nuclear matrix (Bernhard,
1969). These structures could be distinguished by EDTA regressive
staining electron microscopy which preferentially bleaches the DNA
containing euchromatin and reveals an extensive fibrogranular
network which radiates from the interior of the nucleus to the
nuclear pore complexes of the nuclear envelope (Monneron and
Bernhard, 1969). The structural integrity of the fibrogranular
network was shown to require protein since it could be digested
with pepsin (Smetanna et al., 1971). Whole mount electron
microscopy of nuclei after high salt and detergent extraction, and
deoxyribonuclease and ribonuclease digestion, revealed an
intranuclear matrix composed of 200-300 nm fibers which were
termed matrixin (Comings and Okada, 1976). In total, these
observations led to the perception of a skeleton-like structure
which supported the chromatin and nucleolus and gave the nucleus
its overall shape and form. Subsequent analysis showed that certain
regions along the cellular genome were preferentially bound to this
skeleton-like structure (Cook and Brazell, 1975; Callan, 1977;
Paulson and Laemmli, 1977; Hancock and Hughes, 1982). These
attachment regions were shown to be sites of active replication and
transcription (Berezney and Coffey, 1975; Pardoll et al., 1980;
Robinson et al., 1982;Ciejek et al., 1983). These observations
generated numerous models regarding the role of the nuclear matrix
in organizing and coordinating the cellular genome as a whole
(Jackson and Cook, 1985; Gasser et al., 1989, Cook, 1991; Berezney
et al., 1995; Razin et al., 1995).
A. The Nuclear Matrix
The in situ nuclear matrix can be isolated for analysis by
removing the nuclear membrane, soluble proteins, histone and
non-histone proteins, and DNA from intact eukaryotic nuclei.
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Although a number of groups have devoted their research toward
characterizing the in situ nuclear matrix since the mid 1970s, and
over 1000 papers have been published in this field, a precise
definition for its structure has not emerged. This is because the
nuclear structure that remains after extensive biochemical
treatments is operationally defined by the protocol used to isolate
it. Many such protocols have been developed for the isolation of the
in situ nuclear matrix and therefore many definitions of the in situ
nuclear matrix exist. In addition, it has been argued that the in situ
nuclear matrix prepared by the stepwise fractionation of the nucleus
may be an altered or reorganized form of the in vivo nuclear matrix.
There are however some aspects of all in situ nuclear matrix
preparations which are the same and therefore suggest that the
residual structures are not artifacts of the procedures used to
isolate them. The common feature of all in situ nuclear matrix
preparations, as visualized by electron microscopy, is a filamentous
meshwork ramifying the interior of the nucleus surrounded by a
lamina with its embedded nuclear pores. Therefore, although the
exact composition of the in situ nuclear matrix continues to be the
subject of controversy, its existence in vivo is no longer debated
(Lewin, 1994).
The in situ nuclear matrix was first isolated by a stepwise
fractionation of rat liver nuclei (Berezney and Coffey, 1974). This
protocol requires isolated nuclei purified of contaminating
cytoplasm by high speed centrifugation through 2.2 M sucrose. The
nuclei are extracted with 0.2 mM MgCl2 followed by a low speed
centrifugation to remove 75% of the total DNA, 52% of the total
protein, 20% of the total RNA, and 3% of the total phospholipid. The
resulting nuclei remnants are further extracted with 2 M NaCI which
removes an additional 32% of the total protein, 23% of the total
DNA, 46% of the total RNA and 3.5% of the total phospholipid. The
nuclear remnants are then extracted with the detergent Triton
X-100 which removes an additional 6% protein, 0.1% DNA, 5% RNA,
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and 92% phospholipid. Finally, most of the remaining DNA is
removed by treatment of the nuclear remnant with
deoxyribonuclease. The resulting structure contains 10% of the
total nuclear protein, 1.9% of the total DNA, 29% of the total RNA
and 1.5% phospholipid. Visualization of the residual structure using
light microscopy shows that it retains the size and shape of the
original nucleus and it retains recognizable nuclear structures such
as the peripheral lamina with nuclear pore complexes, residual
nucleoli, and an internal fibrogranular network. Whole mount
electron microscopy of the residual structure shows a dense
network of interconnected fibers which have a diameter of ~10 nm
(Berezney et al., 1995). Two-dimensional SDS-polyacrylamide gel
electrophoretic analysis of the proteins in this in situ nuclear
matrix preparation shows a very complex polypeptide profile with
approximately 12 major proteins and 50 minor proteins (Nakayasu
and Berezney, 1991). No histones are present. Polyclonal antibodies
generated for the 12 major proteins cross reacted with lamins A, B,
and C, (the most abundant nuclear matrix proteins), the nucleolar
protein B-23, and core hnRNP proteins. The other eight major
proteins did not show a relationship to any other known proteins and
have been named the nuclear matrins. The matrins are currently
being cloned and characterized.
Critical analysis of the high salt method of extraction
revealed that elongating transcription complexes and their
associated nucleic acids co-precipitated with the in situ nuclear
matrix prepared by 2 M NaCI extraction of nuclei (Kirov et al., 1984;
Lewis et al., 1984; and Roberge et al., 1988). To avoid the
co-precipitation of transcription complexes during nuclear matrix
preparation, the Laemmli group developed a different protocol for
isolating the nuclear matrix which used the ionic detergent lithium
3,5-diiodosalycilate (LIS) instead of high salt solutions for
extraction (Mirkovitch et al., 1984, 1986, and 1988). This
chaotropic agent had been used previously to characterize plasma
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membrane glycoproteins and had also been used to quantitatively
strip cellular chromatin of histones (Robinson and Jencks, 1965;
Marchesi and Andrews, 1971). This technique incorporates a heat
stabilization step just prior to extraction which irreversibly
insolubilizes a subset of nuclear proteins (Lebkowski and Laemmli,
1982). The elimination of this step results in a selective
enrichment of lamina proteins relative to internal matrix proteins
(Izaurralde et al., 1988). Restriction endonuclease digestion of the
extracted nuclei removes 75-95% of the total nuclear DNA. Although
the structural morphology, as determined by light microscopy, and
the polypeptide profiles, as determined by SDS-PAGE, of the in situ
nuclear matrices from both methods of extraction are similar
(suggesting similar biochemical composition), LIS extraction does
not co-precipitate transcription complexes (Mirkovitch and Laemmli,
1984; Roberge et al., 1988; Belgrader et al., 1991). The nuclear
remnant resulting from this method of nuclei extraction has been
called the in situ nuclear scaffold to distinguish it from nuclear
remnant structures prepared using other methods of nuclei
extraction.
The high salt and LIS nuclei extraction methods were
criticized by some who believed the residual structures obtained by
these methods were due to artifactual precipitation of proteins
during the relatively harsh treatment of the nuclei. The Cook group
therefore devised a method of preparing the in situ nuclear matrix
under "physiological" conditions (Jackson and Cook, 1985). An
isotonic salt concentration is not usually used during nuclear
fractionation because it causes the precipitation and aggregation of
chromatin into an unworkable mass. This can be overcome if whole
cells are encapsulated in agarose microbeads (50-150 /vm diameter)
which are permeable to small molecules and enzymes and which
prevent chromatin aggregation (Cook, 1984). The encapsulated cells
are permeabilized in the mild detergent Triton X-100 which removes
75% of total cell protein and 90% of total cell RNA. The cell
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remnants are then treated with a restriction endonuclease and 95%
of the chromatin is removed by electroelution. All of these steps
are carried out under physiological conditions of ionic strength, pH,
and temperature. Electron microscopy of resinless thin sections of
this nuclear matrix preparation shows a meshwork of branched
filaments which have a diameter of 10 nm and an axial repeat of
23 nm (Jackson and Cook, 1988). These are the same dimensions as
that of cytoplasmic intermediate filaments, however the nuclear
network is denser than the cytoskeleton. The branched filaments are
also the same diameter as the interconnected fibers of the Berezney
and Coffey high salt in situ nuclear matrix. The internal meshwork
is bounded by a nuclear lamina containing embedded nuclear pores.
Cook has named the nuclear remnant resulting from this method of
nuclei extraction the in situ nuclear skeleton to distinguish it from
nuclear remnant structures prepared using other methods of nuclei
extraction. The meshwork has been named the in situ nuclear
skeleton core filament structure. The residual cells retain their
replication capability as determined by the incorporation of [3H]
thymidine triphosphate into nascent DMA (Jackson and Cook, 1986;
Cook 1991). This DMA synthesis activity only occurs in nuclear
matrix preparations from cells in S phase. The residual cells have
associated RNA polymerase II and are capable of transcription as
determined by the incorporation of [32P] uridine triphosphate into
acid-insoluble RNA (Jackson and Cook, 1985; Cook, 1994). This
method of nuclei extraction therefore does not detach replication or
transcription complexes.
It was suggested the high salt and LIS extraction methods
altered the form and composition of the in vivo nuclear matrix and
that resin embedded, thin section electron microscopy did not
adequately represent the structural aspects of a three dimensional
nuclear matrix. The Penman group therefore developed a nuclei
extraction protocol which resulted in a nuclear remnant structure
they considered a more accurate representation of the in vivo
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nuclear matrix (Fey et al., 1986). This method uses whole cells
which are stepwise extracted to avoid anomalous precipitation or
solubilization of nuclear components. Cells are first permeabilized
with Triton X-100 and chromatin is removed using DNase I. The
cells are then extracted with 0.25 M ammonium sulfate followed by
an additional extraction with 2 M NaCI. This procedure results in the
removal of >97% of the nuclear DNA, >95% of histone proteins, 70%
of the non-histone nuclear proteins, and 70% total cell lipids. The
remaining nuclear structure is visualized by embedment-free
thick-section electron microscopy (He et al., 1990). This technique
reveals a highly branched network of filaments with smooth
junctions bounded by a lamina at the periphery of the nucleus. The
filaments have an average diameter of 10 nm. The network was
similar to that observed in the high salt in situ nuclear matrix and
in the in situ nucleoskeleton isolated under physiological conditions.
Electron micrographs of cells which were extracted with 2 M NaCI
directly, without an intermediate, 0.25 M ammonium sulfate
extraction, showed an amorphous nuclear interior which the authors
suggest is formed by the aggregation of core filaments. It has
subsequently been shown that the intermediate salt concentration
extraction step avoids the coprecipitation of RNA polymerases and
therefore this isolation protocol does not co-precipitate
transcription complexes (Roberge et al., 1988).
Penman's group has analyzed the effects of RNase treatment of
nuclei during the various steps of the in situ nuclear matrix
isolation protocol. Extensive RNase treatment of nuclei remnants
after high salt extraction results in the removal of 97% of the
hnRNA and its associated proteins, and in the complete collapse of
the internal core filament structure leaving essentially an empty
lamina. Additional evidence that the nuclear matrix has an RNA
component was obtained by [3H] uridine labeling HeLa cells followed
by analysis of labeled RNA within the various nuclear fractions
obtained during the extraction procedure. The majority of the label
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was found within the final nuclear matrix fraction. Their conclusion
is that RNA is a vital structural component of the nuclear matrix.
The RNA consisted both of ribosomal RNA precursors and very high
molecular weight hnRNA with a modal size of 20 kb. Cook's group
has also treated nuclei remnants with RNase and have come to the
conclusion that RNA is not required for the integrity of the nuclear
matrix core filament structure. The discrepancy in the conclusions
of these two groups regarding RNA as a structural component of the
nuclear matrix may be due to the differences in the isolation
protocols.
Regardless of the protocol used to isolate them, all in situ
nuclear matrix preparations show a nuclear lamina with embedded
nuclear pores at the periphery of the residual nucleus. In intact
cells the lamina underlies the inner membrane of nuclear envelope
and is emmbedded with nuclear pores (Gerace and Blobel, 1980). The
lamina is ~10 nm in thickness and is composed of protein sub-units
called lamins which have an axial repeat of 25 nm (Weber and
Geisler, 1985). Lamins are filamentous polypeptides which are
classified as type V intermediate filaments. Lamins fall into two
sub-groups, group A and group B. Group A lamins are comprised of
lamin A and lamin C which are the products of alternatively spliced
messages from the same gene (Mckeon et al., 1986). The Group A
lamins are expressed only in differentiated cells. There are two
members of the group B lamins, Bi and Bz, which arise from distinct
genes. The B lamins are expressed constitutively in all embryonic
and somatic tissues although different cells may express one or the
other. Like all intermediate filament proteins, lamins are composed
of a short N-terminal (head) domain, a central alpha helical rod
domain, and a C-terminal (tail) domain (Hennekes and Nig, 1994;
Firmbach et al., 1995). At the first level of polymerization, lamins
form a parallel unstaggered dimer through coiled-coil formation of
the rod domain. Dimers then form filaments through longitudinal
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head to tail interactions and several types of lateral interactions
(Heitlinger et al., 1992; Heins and Aebi, 1994; Glass et al., 1993).
The identity of the protein component(s) of the nuclear
matrix/scaffold/skeleton core filaments has not been determined
precisely. It has been observed that the proteins in the intermediate
filament family are components of filamentous structures which
have a diameter of 10 nm and 23 nm axial repeats. Resinless thin
section electron microscopy of the nuclear scaffold immunolabeled
with gold particles using monoclonal antibodies specific for protein
lamin B (Hozak et al., 1995), and a pan intermediate filament protein
antibody (Lebel and Raymond, 1987; Hozak et al., 1995) supports the
concept of an intermediate filament nuclear scaffold core (Jackson
and Cook, 1988) although this work could not be repeated by other
groups (Nickerson and Penman unpublished observations). Still,
intermediate filament proteins, including the lamins, bind DNA
and/or chromatin (Shoemann and Traub, 1990; Glass and Garace,
1990; Hoger et al., 1991) and rat liver lamins bind with high affinity
to DNA sequences which associate with the nuclear
matrix/scaffold/skeleton. Due to its presence in in vitro nuclear
matrix preparations and its propensity to form long coiled-coiled
structures, similar to the structures formed by proteins such as
intermediate filaments, actin, and myosin heavy chains, it has been
proposed that the nuclear mitotic apparatus protein (NuMa) is a core
filament protein (Lydersen and Pettijohn, 1980;Tousson et al.,
1991). Immunogold labeling of the core filament network with
antibodies specific for NuMa (Zeng et al., 1994) support this view
although this work could not be repeated in other labs using other
NuMa specific antibodies (Nickerson and Penman, unpublished
observations). Using resinless thin section electron microscopy
other studies suggest that the well characterized cytoskeletal
intermediate filament protein vimentin is a component of the
internal nuclear matrix (Fey et al., 1986) although these results
could not be repeated by others using different vimentin specific
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antibodies (Hozak and Cook, unpublished observations). Other
reports suggest the thin filament protein nuclear actin is a
component of the core structure (Fey and Penman, 1988; He et al.,
1990). The difficulty in identifying the core filament proteins with
certainty is due to the lack of quantitative immunolabeling by any of
the specific antibodies that have been tested. In addition, the core
filament proteins are relatively insoluble and are therefore difficult
to analyze biochemically.
B. Genome Organization and the Radial Loop Model
Several lines of evidence have led to the conclusion that
eukaryotic chromatin is organized into topologically separate loop
domains. Electron microscopy of meiotic lampbrush chromosomes
within the nuclei of living amphibian oocytes showed a succession
of chromatin loops attached to a skeleton like core (Callan, 1977).
This loop organization was shown to characterize the DMA in
isolated interphase chromosomes in which histones were removed
using heparin sulfate or 2 M NaCI (Hancock and Hughes, 1982).
Fluorescent microscopy of high salt extracted nuclei, which have not
been treated with DNase I or restriction endonucleases, shows loops
of DNA extruding from the lamina and remnant nuclear pore
complexes to form the so called halo structures (Cook and Brazed,
1975, 1976; Vogelstein et al., 1980; Gerdes et al., 1994). The loop
domains have been shown to have negative superhelicity which are
maintained by the attachment to the matrix and which can be relaxed
using intercalating agents such as ethidium bromide (Cook and
Brazed, 1975, 1976). Variations in superhelicity are effected by
changes in ethidium bromide concentration and are measured by
changes in sedimentation coefficient when the nuclei are
centrifuged through a sucrose gradient. An increase in ethidium
bromide through a range of concentrations results in a decrease in
negative superhelicity which is measured as a decrease in the
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sedimentation coefficient.
At a critical ethidium bromide
concentration the loop domains are completely relaxed and further
increases in the intercalating agent result in an increase in positive
superhelicity which is measured as an increase in the sedimentation
coefficient. The radius of the halo also correlates with changes in
superhelicity. The radius increases with a decrease in negative
superhelicity until the loops are completely relaxed, after which
increasing positive superhelicity decreases the size of the halos. By
directly measuring the radius of the mouse 3T3 halo when the loops
were in the relaxed state, and therefore fully extended, the average
size of an individual loop domain was 30 ^m (Vogelstein et al.,
1980). Since 1 ^ym is approximately equal to 3 kb, the loop domains
were estimated to be 90 kb. Comparing the size of the rat genome to
the percentage and average size of DNA in the nuclear matrix after
2 M NaCI extraction and DNase I treatment of nuclei, estimates the
average size of the loop domain to be 80 kb in both rat liver cells
(Berezney and Buchholtz, 1981) and in human HeLa cells (Mullenders
et al., 1983). Finally, electron microscopy of an isolated human HeLa
metaphase chromosome from which histones had been removed using
2 M NaCI shows loops of DNA extruding from a central scaffold or
core structure (Paulson and Laemmli, 1977). Measurement of these
loop domains size shows the average loops are between 30-90 kb.
Attachment of the cellular genome at dispersed intervals along
each chromosome to the nuclear matrix, thereby organizing the DNA
into chromatin loops, achieves the high order chromatin structure
necessary to package the DNA into the eukaryotic nucleus. The
length of DNA present within a single human cell is approximately
one meter long when fully extended. This length of DNA must be
condensed several thousand-fold to fit inside an interphase
eukaryotic nucleus with a diameter of 10 /ym. Complexation of the
DNA with histone octamers results in the beads-on-a-string array of
nucleosome core particles (Oudet et al., 1975) and histone H1
achieves a 40-fold condensation by the formation of first the 10 nm
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nucleosomal fiber (Griffith, 1975; Finch et al., 1975), and then the
30nm solenoidal fiber (Finch and Klug, 1976). Subsequent
attachment of the DNA to the nuclear matrix organizes the DNA into
large chromatin loops which condenses the chromatin an additional
50-fold. The chromatin loops can then further coil or condense upon
themselves to achieve the additional compaction necessary to fit
into the interphase nucleus.
C. Nuclear Matrix Attachment Regions
Characterizing the DNA sequences which serve to anchor the
cellular genome to the nuclear matrix has been attempted using a
number of techniques. Analysis of the 0.1% of the total nuclear DNA
which remained after treating 2 M NaCI extracted nuclei with DNase
I, showed this DNA to be between 50 and 200 bp (Cook and
Brazell,1980; Ciejek et al., 1983; Jost and Seldran, 1984). These
fragments could not be removed from the in situ nuclear matrices by
repeated extractions with 2 M NaCI or by density centrifugation in a
cesium chloride gradient (Jackson et al., 1984). They were therefore
assumed to represent chromatin loop ends immersed into the in vivo
nuclear matrix. Analysis of the sequence specificity of these small
fragments by several groups resulted in different conclusions. Some
authors found the reassociation kinetics of these fragments to be
identical to total eukaryotic genomic DNA (Basler et al., 1981;
Bowen et al., 1981). Other authors have found these fragments
renature quickly relative to total DNA (Opstelton, 1989). When the
fragments were cloned and sequenced no consensus or specific DNA
recognition element could be found (Goldberg et al., 1983;
Kalandadze et al., 1988; and Opstelten et al., 1989). When the high
salt isolation protocol was analyzed critically it was found that
elongating transcription complexes co-precipitated with the in situ
nuclear matrix prepared by this method (Kirov et al., 1984; Roberge
et al., 1988). It was argued that the DNA sequences identified as
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associating with this in situ nuclear matrix could be sequences
associated with active genes and not sequences which interacted
with the in vivo nuclear matrix. Different approaches of identifying
DNA sequences which interact with the in vivo nuclear matrix were
therefore developed. Matrix attachment regions (MARs) have been
defined by their capability to bind to the nuclear matrix in an in
vitro binding assay (Cockerill and Garrard, 1986). This assay
utilizes in situ nuclear matrices prepared by the high salt isolation
protocol, however, to this is added a pool of exogenous radiolabled
DNA fragments which are to be tested for their nuclear matrix
binding capability. The exogenous fragments which bind the in situ
nuclear matrix are defined as MARs. Although there is a wide range
of binding specificity among a given pool of test fragments, it has
not been shown that the fragments which bind to the nuclear matrix
in vitro , are located at the base of the DNA loop domains in vivo. In
addition, the association of MAR elements with in situ nuclear
matrices do not withstand extraction with 2 M NaCI (Vassetzky et
al., 1989). Scaffold attachment regions (SARs) have been defined as
the DNA which remains associated with the in situ nuclear matrix
prepared by LIS extraction of nuclei followed by the removal of
chromatin by restriction endonuclease digestion (Mirkovitch et al.,
1984). Of all the nuclear matrix preparation protocols which have
been developed, this is the most widely used method for mapping
DNA sequences within the genome which attach to the in situ nuclear
matrix. It has not been determined definitively that the DNA
sequences isolated by this method are located at the base of
chromatin loop domains in vivo.
Combined there have been over 50 MARs and SARs isolated
from organisms spanning evolution, including yeast (Amati and
Gasser, 1988), plants (Dietz et al., 1994), insects (Gasser and
Laemmli, 1986), chickens (Phi-Van and Stratling, 1988), mice (Xu et
al., 1989), and humans (Levy-Wilson and Fortier, 1989). This
suggests that they are a well conserved structural element of
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eukaryotic DNA. Although the DNA fragments containing them have
been cloned and sequenced, no consensus sequence for SAR and/or
MAR DMAs has been determined. The two common characteristics
shared by all MARs and SARs however, are that they are between 500
and 1000 bp in length and are >60% dA • dT rich. They frequently
contain perfect and inverted repeat sequences (Jackson et al., 1984;
Boulikas and Kong, 1993). They are generally but not always located
near cis-acting regulatory elements such as enhancers (Cockerill
and Garrard, 1986; Levy-Wilson and Fortier, 1989; Stratling et al.,
1986), associated with DNase I hypersensitive regions of active
chromatin (Levy-Wilson and Fortier, 1989; Phi-Van and Stratling,
1988), and contain topoisomerase concensus recognition and
cleavage sequences (Cockerill and Garrard, 1986a; Cockerill et al.,
1987). Most significant, a number of DNA fragments originally
defined as MARs can also be defined as SARs and visa versa. For
example, the regulatory regions of the human immunoglobulin kappa
gene (Cockerill and Garrard, 1986), the human apolipoprotein B gene
(Levy-Wilson and Fortier, 1989), the chicken lysozyme gene
(Stratling et al., 1986; Phi-Van et al., 1988), the Drosophila histone
cluster genes (Izaurralde et al., 1988; Gasser and Laemmli, 1986),
and the mouse and human interferon-B genes (Bode and Maas, 1988)
contain sequences which have been shown to bind the nuclear
matrix/scaffold in both the in vitro nuclear matrix binding assay and
in the in situ nuclear scaffold binding assay.
The inability to define a significant consensus sequence is
most probably because the S/MAR-scaffold/matrix complexes are
very large and involve multiple protein-DNA interactions (Gasser and
Laemmli, 1986; Jackson et al., 1990). It has been shown that
S/MARs are capable of becoming stabile base-unpaired when
subjected to the torsional stress of negative supercoiling (Bode et
al., 1992). For example, the 800 bp MAR located 5' of the human
interferon-B gene forms single stranded non B-DNA, when inserted
upstream of an active SV40 promoter fused to a luciferase reporter,
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and stabile transformed into mouse L cells. When the gene is active
base unpairing in this region can be detected by the chemical probe
chloroacetaldehyde which specifically modifies the N-3 and N-4
positions of unpaired cytosine and the N-1 and N-6 positions of
unpaired adenine (Kohwi-Shigematsu and Nelson, 1988). When target
A and T nucleotides of the MAR are mutated to C and G nucleotides,
the promoter activity decreases 8-fold, the region no longer forms
single stranded structures, and the fragment no longer binds to the
nuclear matrix in an in vitro binding assay (Bode et al., 1992). It has
been proposed that S/MARs propensity to form single stranded DNA
structures confers these sequences with nuclear matrix binding
capability. Alternatively, it has been shown that oligo(dA) •
oligo(dT) sequences within the dA ■ dT rich regions of S/MARS form
DNA structures with an unusually narrow minor groove (Nelson et al.,
1987). The anti-tumor drug distamycin binds specifically to the
narrow minor groove of the Drosophila histone gene S/MAR and
concomitantly inhibits the binding of this S/MAR to the nuclear
matrix (Kopka et al., 1985). It has therefore been proposed that the
narrow minor groove present in S/MARs is recognized by the
proteins of the nuclear matrix. Although the mechanism of S/MAR
binding to the nuclear scaffold/matrix has not been determined, it is
probable that dA ■ dT rich sequences form unique DNA structures
which can be recognized without reading the nucleotide sequence in
the major groove.
D. Functional Coordination of the Genome By the Nuclear Matrix
A number of studies have shown a correlation between the
association of the nuclear matrix and newly synthesized DNA (Cook,
1991; Berezney et al., 1995). Kinetic analysis of the distribution of
[3H] thymidine in nuclear matrix halos isolated from regenerating rat
livers by 2 M NaCI extraction, showed that one minute after rats are
injected with the label more than 90% of the total tritium is
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associated with the core matrix DNA (Berezney and Coffey, 1975).
In these preparations this DNA comprises only 25% of the total DNA.
As time post injection increases there is a corresponding decrease
in the percentage of label within the core matrix and an increase in
the percentage of label out in the loops of the halo. The
interpretation of these results is that DNA synthesis is initiated at
the base of the DNA loops within the core matrix. Other studies
analyzed exponentially growing 3T3 fibroblasts which were pulse
labeled with [3H] thymidine and analyzed for the distribution of label
between the core matrix DNA and loop DNA as a function of the
extent of DNase digestion (Pardoll et al., 1980). At short pulse
times and short DNase digestion times the percentage of total DNA
associated with the matrix is relatively high and the percentage of
total label associated with the matrix is relatively low. As the
DNase digestion time increases the percentage of total DNA
associated with the matrix decreases and the percentage of total
label associated with matrix increases. The selective enrichment of
total label in the matrix fraction with an increase in DNase
digestion time does not occur at long pulse times. The
interpretation of these results is that DNA replication in eukaryotic
cells occurs at fixed sites upon the nuclear matrix. To obtain visual
evidence that newly synthesized DNA is associated with the nuclear
matrix, Namalwa B-lymphoma cells synchronized in S-phase, were
pulse labeled with the modified nucleoside bromodeoxyuridine
(BrdU), and nuclear halos were prepared by 2 M NaCI extraction at
various chase times (Gerdes et al., 1994). The halos were visualized
by fluorescence microscopy after immunolabeling with a fluorescein
labeled monoclonal antibody specific for BrdU. At short chase times
the nuclear halos show discrete cluster patterns all of which are
contained within the core matrix. As the chase time increases the
label progressively moves out onto the extended loop portion of the
halos. These results are consistent with the concept that there is a
preferential localization of replicating DNA to fixed sites at the
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bases of chromatin loops. Finally, the average loop size of 90 kb
correlates with the average size of eukaryotic replicons as
determined by DNA fiber autoradiography and electron microscopy,
prompting the model that each loop domain is an individual unit of
replication (Buongiorno-Nardelli et al., 1982).
A number of studies have shown a correlation between the
association of the nuclear matrix and replicative enzymes, When the
nuclear matrix is prepared from regenerating rat liver cells in the S
phase of the cell cycle by 2 M NaCI extraction it coprecipitates with
DNA polymerase alpha (Smith and Berezney, 1980; Foster and
Collins,1985). Other replication complex enzymes such as DNA
primase, DNA methylase, S'-S' exonuclease, and ribonuclease H, are
also associated with the high-salt resistant nuclear matrix prepared
from these cells (Tubo and Berezney, 1987a). Mild sonnication of
these nuclear matrix preparations releases the DNA polymerase and
primase activities as megacomplexes which sediment at 100-150 S
and which are capable of synthesizing DNA in vitro (Tubo and
Berezney, 1987b). In contrast, nuclear matrices prepared just
before the onset of in vivo replication are devoid of megacomplexes.
Visual evidence that replication enzymes and DNA synthesis occur on
the nucleoskeleton has been shown in HeLa cells synchronized in S
phase (Hozak et al., 1993). The sites of DNA synthesis within the
nucleus of the cells were labeled by the incorporation of
biotin-11-DTP. The labeled cells were encapsulated in agarose
beads, permeabilzed with streptolysin O, and double digested with
Hae III and EcoRI. Electroelution removed 90% of the total nuclear
DNA. The incorporated biotin remaining with the nucleoskeleton was
indirectly immunolabled with a goat anti-biotin antibody and
visualized using thick resinless section electron microscopy. Within
the nuclear region, residual clumps of chromatin could be seen
dispersed in a network of core filaments. In addition, the sites of
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biotin incorporation were morphologically discreet, densely staining
ovoid bodies attached to the network at regular intervals.
These sites co-labeled with antibodies specific for DNA polymerase
alpha and for the replication associated proliferating cell nuclear
antigen (PCNA) and have been designated replication factories.
A number of studies have shown a correlation between cell
type specific binding of genes to the nuclear matrix/scaffold and
their expression. The most convincing biochemical results were
obtained by analyzing the chicken ovalbumin gene (Robinson et al.,
1982; Ciejek et al., 1983). The ovalbumin gene is expressed in the
oviduct of the mature chicken and is found associated with the in
situ nuclear matrix prepared by high salt extraction of oviduct cell
nuclei. Conversely, the gene is not expressed in the liver and is not
associated with the matrix in hepatocytes of this organ. As a
negative control it was shown that the B-globin gene which is not
expressed in the oviduct does not associate with the nuclear matrix.
These results were repeated and expanded to show that the
ovalbumin gene which is not expressed in the oviduct in immature
chicks, does not associate with the matrix. Hormonal stimulation of
the chicks results in ovalbumin gene expression and association
with the matrix in the oviduct. Upon subsequent withdrawal of the
hormone the ovalbumin gene transcription is discontinued and the
gene no longer associates with the oviduct matrix. Other
researchers showed that the chicken vitellogenin II gene which is
expressed in the liver associates with the matrix in the cell of that
organ (Jost and Seldran, 1984). The vitellogenin II gene is not
expressed in the chicken oviduct and is not associated with the
matrix. Still other researchers showed an enrichment of the
B-globin gene in the nuclear matrix of chicken erythrocytes in which
the gene is expressed (Hentzen et al., 1984). Conversely, the
ovalbumin gene, which is not expressed in erythrocytes, was not
enriched in the nuclear matrix fraction of this cell type.
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Visual evidence that active genes are associated with the nuclear
matrix has been obtained by biochemical fractionation of nuclei to
produce "halos" coupled to high resolution fluorescence
hybridization with probes specific for expressed and non expressed
genes (Gerdes et al., 1994). Namalwa human B lymphocytes express
the ribosomal protein RPS4X gene, the histone H3 and H4 gene, and
the U2 snRNA gene cluster. These cells do not express the
dystrophin or alpha-cardiac myosin heavy chain genes.
Differentially labeled fluorescent probes for each of these genes,
simultaneously hybridized with nuclear halos prepared by 2 M NaCI
extraction of these cells, showed the expressed genes were at the
nuclear matrix core while the non-expressed genes were out in the
DNA loop region away from the central core.
The correlation between the transcriptional activity of a given
gene and its association with the nuclear matrix was questioned by
the results of studies done on the alpha-globin gene in Friend
leukemia cells (Kirov et at., 1984). In these cells the alpha-globin
gene is not expressed and it is also not bound to the nuclear matrix.
Friend cells can be induced to express the gene by exposure with low
concentrations of butyrate and it was shown that the gene binds the
nuclear matrix in the treated cells. When the nuclei from induced
cells were treated with DNase I prior to extraction with 2 M NaCI
however, the alpha-globin gene was no longer matrix-bound. The
interpretation was that the 2 M NaCI extraction causes the
precipitation of transcription complexes and ribonuclear proteins
such that any active gene would be protected from DNase I if nuclei
were first extracted with high salt. This interpretation was
challenged when it was shown, using the original order of
operations, that the inhibition of transcription by either
alpha-amanitine or by actinomycin D does not cause the detachment
of otherwise active genes from the nuclear matrix (larovaia et al.,
1985; Small et al., 1985). In addition, the arrest of transcription of
normally active genes by heat shock treatment does not affect the
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attachment of these genes to the nuclear matrix (Small et al., 1985).
Also, kinetic analysis of both the attachment of vitellogenin II gene
with the nuclear matrix and mRNA synthesis in immature chickens,
after the expression of the gene is induced with the hormone
estradiol, suggested that matrix attachment occurs prior to
transcription initiation (Jost and Seldran, 1984).
Finally,
subsequent analysis of the alpha-globin gene, using a protocol in
which nuclei were treated with DNase I prior to 2 M NaCI extraction,
showed there is a correlation between nuclear matrix binding and
transcription activity in chicken erythroblasts and mature
erythrocytes in which the gene is active and inactive, respectively
(Farache et al., 1990). These studies suggest that the association of
a gene with the nuclear matrix is a condition of, rather than a
consequence of, transcription activation. Nonetheless, most
researchers who use the high salt extraction protocol have since
reversed the original order of operations and now treat nuclei with
DNase I prior to 2 M NaCI extraction when preparing the in situ
nuclear matrix.
Although S/MARs do not affect gene expression in transient
transfection assays (Stief et al., 1989; Poljak et al., 1994), they do
activate the genes they are associated with when tested in stabile
transformed cells. The mouse interferon 8 gene is contained within
a 21 kb domain which is flanked by DNA regions which bind to the
nuclear matrix in in vitro and in situ binding assays (Bode and Maas,
1988; Mielke et al., 1990). These flanking regions increase the
transcriptional activity of the interferon gene 20 to 30-fold, in an
orientation- and partly distance-independent manner, when the gene
is stabile transfected into mouse L cells, relative to a transfected
interferon construct from which the flanking regions have been
deleted (Klehr et al., 1991). The chicken lysozyme gene is flanked by
S/MARs which coincide with the 5' and 3' boundaries of general
DNase sensitivity of this presumed loop domain. When a CAT
reporter gene, placed downstream of the lysozyme enhancer, is
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flanked by the S/MAR elements of the lysozyme gene domain, its
expression in stabile transfected chicken pro-macrophage cells is
elevated approximately ten-fold, relative to a lysozyme
enhancer/reporter gene without the flanking S/MARs (Stief et al.,
1989). This increase in gene activity is proportional to the number
of copies integrated and this proportionality is seen in a number of
different clones suggesting the activation is independent of the
position of chromosome integration. The chicken lysozyme 5' S/MAR
also will activate the herpes simplex thymidine kinase promoter in
stabile transfected rat fibroblasts, suggesting that this S/MAR can
modulate transcription in different species using heterologous
promoters (Phi-Van et al., 1990). The Drosophila histone gene
S/MARs, present within the non-transcribed spacer between the HI
and H3 genes, when placed upstream of the SV40 enhancer which has
been fused to a CAT reporter, shows a twenty-fold increase in gene
activity when transformed into HeLa cells, relative to the same
construct which is not flanked by histone gene MARs (Poljak et al.,
1994). A S/MAR located upstream from the enhancer of the mouse
kappa light chain immunoglobulin gene has been shown to increase
the expression of the gene 4-fold when stabile transformed into
plasmacytoma cells, relative to cells transformed with a construct
in which the S/MAR has been deleted (Blasquez et al., 1989). The
same S/MAR sequence increased the kappa gene expression 3-fold
when transformed into transgenic mice (Xu et al., 1989). Therefore,
these example sequences which bind to the nuclear matrix in vitro
and bind to the nuclear scaffold in situ also activate reporter gene
transcription when associated with an enhancer in stabile
transfected cells.
Several models have been proposed to explain the mechanism
by which S/MARs activate transcription in stabile transformed
cells. S/MARs may activate transcription by generating the
necessary torsional stress in DNA needed for efficient transcription
initiation complex formation. By anchoring the linear chromosome
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molecule to the nuclear matrix, S/MARs allow for the formation of
negative superhelical DNA structures which are recognized and
bound by transcription factor TF-IID (Mitzutani et al., 1991).
Alternatively, stable base unpairing within the S/MAR may relieve
the negative superhelical strain that occurs upstream of the
transcription complex during initiation and/or elongation (Cockerill
and Garrard, 1986a). S/MARs could therefore be considered long
range modulators of chromosme structre. Finally, S/MARs may
activate transcription by binding to the nuclear matrix thereby
localizing cis-acting regulatory elements to regions in the nucleus
where there is a high concentration of transcription factors (Stein
et al., 1991).
E.

Viral Genome Nuclear Matrix Association

The genomes of eukaryotic DNA viruses have also been shown
to associate with the nuclear matrix in the infected nucleus. The
binding of viral genomes to the nuclear matrix has been correlated
with functions such as viral transcription and viral replication. The
adenoviruses have been shown to bind the in situ nuclear matrix
prepared by high salt extraction of human HeLa cells via the viral
terminal proteins which are covalently bound to the ends of the viral
genome (Schaack et al., 1990; Younghusband and Maundrell; 1982).
This association is required for the efficient expression of the E1A
gene, an immediate early gene, and therefore the initiation of viral
multiplication. It has been proposed that the adenovirus
chromosome exists as a single chromatin domain during infection
and that the binding of DNA to the nuclear matrix plays a critical
role in adenovirus transcription. The Epstein-Barr virus (EBV) has
also been shown to associate with the nuclear matrix (Jankelevich
et al., 1992).
A region of the genome containing the latent origin of
replication binds the matrix in Raji cells which are latently infected
human pre-B lymphocytes. Upon induction of the cells to

25
differentiate with the phorbol ester
12-O-tetradecanoylphorboI-l3-acetate (TPA), the virus reactivates
from a latent life cycle to a lytic life cycle and virus is produced
(Ooka et al., 1983). Subsequent to reactivation there is a change in
the association of the viral genome with the nuclear
scaffold/matrix to a region of the genome containing a lytic origin
of replication (D' Erme et al., 1995). Although all regions of the
viral genome show some affinity with the nuclear scaffold/matrix
relative to the majority of cellular DNA, it has been proposed that
the EBV chromosome also is organized as a single DNA domain and
that site specific association with the nuclear matrix is required
for viral replication. Therefore all the eukaryotic DNA virus
genomes that have been analyzed show an association with the in
situ nuclear scaffold/matrix. There are no published reports
regarding the association of the HCMV genome with the in situ
nuclear matrix.
HCMV is a 240 kb double stranded DNA virus which is
classified in the beta herpes virus group. It is estimated that
50-70% of the industrialized worlds human population is infected
with HCMV. The number of infected individuals in developing nations
approaches 100%. HCMV causes a wide variety of diseases including
congenital malformation in the newborn, spontaneous infectious
mononucleosis in older children and adults, pneumonitis and
septicemia in the immunocompromised adult, and subclinical
infection in the normal healthy adult (Ho et al., 1991). HCMV may
become latent in various organs during primary infection and be
reactivated in later life in response to different stimuli (Weller,
1971). Reactivation from latency and subsequent viral
multiplication occurs frequently in organ and bone marrow
transplant patients receiving high doses of immunocompromising
chemotherapy (Fiala et al., 1975; Ho, 1982; Whitley et al., 1990). In
addition, the number of AIDS patients succumbing to pneumonitis
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due to HCMV reactivation is steadily increasing (International
Conference on AIDS, 1991; Baldanti et al., 1996).
HCMV replicates within the nucleus of the infected cell. After
entry and uncoating in the nucleus, the linear genome circularizes
and then replicates by a process which produces concatemeric
molecules that are subsequently cleaved into unit-length genomes
and packaged (LaFemina and Hayward, 1983; McVoy et al., 1994). At
no time during infection does the viral genome integrate into the
host chromosome. Like other eukaryotic DMA viruses it is possible
that the HCMV viral genome organizes itself in the nucleus by
associating with the nuclear scaffold/matrix either by site specific
or non-site specific attachments along the genome.
The first viral gene to be expressed upon infection is the
major immediate early gene (MIE). The regulatory region of MIE is
composed of a core promoter element located within
(-) 50 to (-) 1 bp upstream of the transcription start site. Within
the region (-) 500 to (-) 50 is an enhancer element and within the
region (-) 1150 to (-) 500 is a regulatory element termed the
modulator. The modulator has been shown to up-regulate MIE
expression in differentiated cell types and down-regulate MIE
expression in undifferentiated cell types (Nelson et al., 1987). The
modulator of MIE has many physical characteristics of a S/MAR. It
contains a dA ■ dT rich region and several inverted repeat sequences.
It also contains regions which are hypersensitive to DNase I (Nelson
and Groudine, 1986) and is capable of forming non B-DNA single
stranded structures (Kohwi-Shigematsu and Nelson, 1988). The
regulatory region of MIE therefore represents a region of the viral
genome which has a high probability of associating with the nuclear
scaffold/matrix.
An association of the HCMV genome with the nuclear matrix
may have functional significance in regards to viral replication and
viral gene expression. The immediate goal of this study is to
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determine whether the human cytomegalovirus (HCMV)
genome associates with the nuclear matrix of infected cells.
Because the regulatory region of MIE has all the sequence
characteristics of a cellular S/MAR, this region of the viral genome
was tested to determine if it fulfilled pertinent criteria defining
cellular S/MARs. The criteria tested are: 1) binding to the nuclear
matrix in an in vitro nuclear matrix binding assay, 2) binding to the
nuclear matrix/scaffold in an in situ binding assay, and 3) activating
transcription in stabile transformed cells. The results indicate that
the MIE region of the genome fulfills these criteria and can
therefore be classified as a S/MAR. The results of the in situ
binding assays suggest that other regions of the viral genome
associate with the nuclear matrix as well.

METHODS AND MATERIALS
Cell Lines and Culture
The THP-1 human leukemic monocyte, the Tera 2 human
embryonic carcinoma, and the MRC5 human lung fibroblast cell lines
were obtained from the American Type Culture Collection. The MRC5
fibroblasts are permissive to HCMV replication.
Undifferentiated
THP-1 and Tera 2 cells are non-permissive to HCMV replication. All
cell lines were maintained in 75 cm2 flasks at 37° C in a humidified
environment with 5% CO2. All culture media was purchased from
Irvine Scientific and was supplemented with 1 mM glutamine, 10%
fetal calf serum, 100 /vg/ml streptomycin, and 100 /vg/ml penicillin.
The THP-1 cells were grown in suspension culture in RPMI 1640
media. In some experiments, THP-1 cells were treated with
12-0-tetradecanoyl-phorbol-13-acetate to a final concentration of
160 nM to produce differentiation into cells with characteristics of
mature macrophages. The differentiated THP-1 cells are permissive
to HCMV replication. The Tera 2 and MRC5 cells were cultured as
monolayers in DME High Glucose media and in DME Low Glucose
media, respectively.
Viral

Infections
The AD169 Strain of HCMV was a generous gift from John Zaia
(City of Hope Medical Center) and was propagated in MRC5
fibroblasts.
Viral particle containing culture media supernatants
from 7, 10, and 14 days post infection were pooled and frozen at
-80° C without preservatives. The titer of HCMV was determined by
immunostaining with a monoclonal antibody specific for the MIE
protein (NEN Dupont). Approximately 104 MRC5 fibroblasts/well
were plated into an appropriate number of wells in a tissue culture
coated 96 well microtiter plate. The cells were infected with serial
10-fold dilutions containing 10'1 to 10'6 the concentration of viral
particles in the stock supernatant. At 6 hr post infection the
infected cells were washed three times with phosphate buffered
(PBS) and air dried for 10 min at room temperature on the air flow
vent of the hood. The cells were fixed by adding 100 [j\ of fixative
28
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composed of 95% ethanol and 5% acetone to each well. Fixation was
at room temperature for 10 min. The cells were washed three times
with PBS, the PBS was removed, and to each well was added 100 jj\
of monoclonal antibody at a concentration of 1.25 ng//7l. The plate
was incubated for 1 hr in a humid chamber at 37° C. The cells were
washed three times with PBS and to each well was added 100 /j\ of
biotinylated anti-mouse antibody at a concentration of 7.5 ng//il.
The plate was incubated for 30 min in a humid chamber at 37° C.
The cells were washed three times with PBS and to each well was
added 100 /j\ of avidin peroxidase from the ABC kit (Vector)
prepared by adding one drop of solution A, containing avidin, and one
drop of solution B, containing peroxidase, to 5 ml of PBS. The plate
was incubated for 30 min in a humid chamber at 37° C and washed
three times with PBS. To each well was added 100 /vl of buffer
containing 3-amino-9-ethyl-carbazol (ABC, Sigma) at a
concentration of 4 mg/ml and 0.006% H2O2. The ABC was prepared by
dissolving in 5 ml of N,N Dimethyl-formamide and 100 fj\ of acetate
buffer composed of 0.2 M sodium acetate and 0.2 M acetic acid. The
plate was incubated for 15 min in the dark at 20° and washed with
PBS three times. Infected nuclei were visualized by light
microscopy and counted for each dilution (Figure 1). The
concentration of the undiluted stock was calculated by
extrapolation.
DNA Constructions and Probes
All DNA was quantitated using a Beckman DU 650
spectrophotometer (Beckman Instruments). The EcoRI genomic
fragments of the AD169 strain of FICMV cloned into pACYC184 were
a generous gift from Deborah Spector (University of California, San
Diego). The constructs pPXCAT and pHXCAT were prepared by cloning
the regulatory region of the MIE gene spanning (-) 1149 to (+) 73 and
(-) 600 to (+) 73 into the Xba I site within the polylinker of the
expression plasmid pCAT-Basic (Promega), respectively.
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Figure 1. A) MRC5 human diploid lung fibroblasts. B) MRC5 human
diploid lung fibroblasts infected with the AD169 strain of HCMV and
avidin peroxidase immunostained 6 hours post infection with a
monoclonal antibody specific for the MIE protein.
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Probes for the in vitro nuclear matrix binding assay were prepared
by digesting the pACYC184/EcoRI J clone containing the MIE gene
with a suitable restriction endonuclease. The resulting fragments
were end labeled by the incorporation of a radioactively labeled
nucleotide using Klenow DNA polymerase. Individual fragments to be
used for probes for the in vitro nuclear matrix, Southern analysis of
the in situ nuclear scaffold binding assays, and Southern analysis of
the stabile transformed cells, were low melting point agarose gel
purified (Gibco BRL). Residual agarose was removed using the
Qiaquick Gel Extraction kit (Qiagen). Fragments were radioactively
labeled using the random prime labeling kit (Stratagene). Briefly,
25 ng of template DNA was mixed in a reaction volume of 34 /vl of
which lOjul was hexamer primer solution. The template DNA was
denatured by boiling for 5 minutes. The reaction was cooled 5 min
at room temperature to allow the primers to anneal to the template.
To this mixture was added 10 jj\ deoxyribonucleotide solution, 5 jj\
of [alpha-32P CTP] (sp. act. = 20.0 mci/ml [Dupont NEN]), and 1 ij\ of
Klenow DNA polymerase. The mixture was incubated for 15 min at
37° C. To stop the reaction EDTA was added to 1 mM. Probes were
purified by phenol extraction and passage over a Sephadex G-50
(Sigma) column.
Isolation of Nuclei for Nuclear Matrix Preparation
Logarithmically growing Tera 2 cells (108 cells) were washed
once in PBS at 25° C. PBS was added to a volume of 5 ml/flask and
cells were detached from flasks by manual scraping. Cells were
pelleted by centrifugation at 800 g for 5 min. Cells were
resuspended in 10 ml of ice cold homogenization buffer (0.5% Triton
X-100, 10 mM Tris-HCI pH 8.0, 1 mM CaCI, 1.5 mM MgCI2, 0.25 M
sucrose, and 0.1 mM phenylmethylsulfonyl flouride (PMSF). Cells
were homogenized in a Dounce homogenizer and completion of lysis
was confirmed by phase contrast microscopy. Nuclei were pelleted
by centrifugation at 1600 g for 5 min and washed once with
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homogenization buffer without Triton X-100.

Nuclei were visualized

by light microscopy to check for residual cytoplasm. The washing
and pelleting steps were repeated until nuclei were free of residual
cytoplasm. Isolated nuclei were used immediately for nuclear
matrix preparation.
Nuclear Matrix Preparation
Nuclei in 2 ml of homogenization buffer without Triton X-100
were digested with 200 /jq DNase I (Boehringer Mannheim) for
60 min at room temperature. The residual nuclei were pelleted by
centrifugation at 1600 g for 5 min and resuspended in 2 ml
homogenization buffer without Triton X-100 and with 10 mM EDTA.
To the residual nuclei were dropwise added 10 volumes of extraction
buffer (2 M NaCI, 10 mM EDTA, 10 mM Tris-HCI pH 8.0, and 0.2 mM
PMSF) while gently mixing. Extraction was allowed to proceed for
10 min at 4° C. The nuclear matrices were washed with storage
buffer (10 mM NaCI, 3 mM MgC^, 10 mM Tris-HCI pH 7.4, and 0.1 mM
PMSF). The nuclear matrices were pelleted by centrifugation at
1600 g for 5 min and resuspended in storage buffer in an equal
volume of glycerol.
In Vitro Nuclear Matrix Binding Assay
Nuclear matrices (2 x 106/reaction) were washed in 50 mM
NaCI, 10 mM Tris-HCI pH 7.4, 1 mM MgCI2, 0.25 M sucrose and
0.25 mg/ml bovine serum albumin (BSA). Nuclear matrices were
pelleted by centrifugation at 1600 g for 5 min and pellets were
resuspended in 100 ml binding buffer (50 mM NaCI, 10 mM Tris-HCI
pH 7.4, 0.2 mM EDTA, 0.25 M sucrose, 0.25 mg/ml BSA). End labeled
DNA fragments (2 ng), and sonnicated E. coli DNA (5 to 500 /vg/ml
final concentration), were added to the nuclear matrices and the
reaction was incubated for 3 hr at 25° C with gentle shaking. Bound
fragments were separated from non-bound fragments by
centrifugation at 1600 g for 5 min. The pellet fraction was washed
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with 500 ml binding buffer and repelleted to remove traces of
unbound fragments. Supernatant and pellet fractions were analyzed
by electrophoresis through a 1.0% agarose gel for 3 hr at 150 volts.
The gel was dried onto nylon membrane (Zeta-Probe, BioRad) and
exposed to x-ray film (Kodak) for 1 to 12 hr without intensifying
Autoradiographs were quantitated by
screens at room temperature.
scanning densitometry using an Alphalmager 2000 Documentation
and Analysis System (Alpha Innotech Corporation).
In Situ Nuclear Scaffold Binding Assay
MRC5 fibroblasts (108 cells) were infected with the AD169
strain of HCMV at a multiplicity of infection of 0.1 to 0.5. At
appropriate times after infection ranging from 6 to 24 hr, infected
cells were washed in (PBS) at 25° C. PBS was added to a volume of
5 ml/flask and infected cells were detached from flasks by manual
scraping. Cells were pelleted by centrifugation at 800 g for 5 min
and washed in 10 ml of ice cold homogenization buffer (3.75 mM
Tris-HCI, 0.05 mM spermine, 0.125 mM spermidine, 0.5 mM EDTA/KOH
pH 7.4, 1% thiodiglycol, 20 mM KCI, and 0.1 mM PMSF). Cells were
pelleted by centrifugation at 800 g for 5 min and resuspended in
10 ml of homogenization buffer containing 0.1% digitonin (Sigma).
Cells were homogenized 15 to 20 strokes in a Dounce homogenizer
with a loose fitting pestle. Completion of lysis and the complete
removal of cytoplasm was confirmed by phase contrast microscopy.
Nuclei were washed in homogenization buffer without EDTA and with
0.1% digitonin, pelleted by centrifugation at 1600 g for 5 min, and
resuspended in 2 ml of the same buffer. Nuclei were heat stabilized
by incubation at 37° for 30 min. To the nuclei were dropwise added
10 volumes of extraction buffer [5 mM HEPES/NaOH pH 7.4, 0.25 mM
spermidine, 2 mM EDTA/KOH pH 7.4, 2 mM KCI, 0.1% digitonin, and
25 mM 3,5-diiodosalicylic acid, lithium salt (Sigma), 0.1 mM PMSF]
while gently shaking on ice. Extraction was allowed to proceed on
ice for 10 min. Extracted nuclei were pelleted by centrifugation at
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1600 g for 5 min and washed 5 times with an appropriate restriction
endonuclease digestion buffer. Extracted nuclei were then digested
with the restriction endonuclease for 12 hr at a concentration of
1000 u/ml. Nuclear matrix bound DNA was separated from
non-bound DNA by centrifugation at 1600 g for 5 min. The pellet
was washed with digestion buffer and digested for an additional 3 hr
at a concentration of 300 u/ml. The nuclear matrix bound and
non-bound DNA were again separated by centrifugation at 1600 g for
5 min and the second supernatant was added to the first. The pellet
was washed with 2 M NaCI to remove artifactual binding of
fragments which may occur during restriction endonuclease
digestion. The pellet and the supernatant fractions were treated
with proteinase K (0.5 mg/ml final concentration) in 1% sodium
dodecyl sulfate (SDS) at 50° C for 3 hr. DNA from both fractions
was isolated by ethanol precipitation in the presence of 300 mM
sodium acetate. Equal concentrations of DNA from each fraction
(10 /vg) were electrophoresed through a 1.0% agarose gel and
analyzed by the Southern method. Briefly, DNA was transferred to a
nylon membrane (Zeta-Probe, Biorad) in a 400 mM NaOH solution by
capillary action. The membrane was neutralized in 2X SSC for 5 min
and air dried for 1 hour. The membrane was placed in 10 ml 0.2 /vm
filtered prehybridization buffer containing 250 mM Na2HPC>4 pH 7.2,
7.0% SDS, and 1 mM EDTA, and incubated at 65° C for 5 min. The
prehybridization buffer was removed and replaced with the same
filtered buffer containing the purified probe which had been
denatured by boiling for 5 minutes. Hybridization was at 65° C for
10 to 14 hr with gentle shaking. The membrane was washed at 65° C
2 times for 30 min each, in 40 mM Na2HP04 pH 7.2, 5% SDS, and 1 mM
EDTA. The membrane was washed at 65° C an additional 2 times for
30 min each, in 40 mM Na2HP04 pH 7.2, 1% SDS, and 1mM EDTA. The
membrane was wrapped in plastic wrap and exposed to X-ray film
(Kodak) at room temperature without intensifying screens for 1 to
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12 hr. Autoradiographs were quantitated by scanning densitometry
using an Alphalmager 2000 Documentation and Analysis System
(Alpha Innotech Corporation).
Stable Transformations
THP-1 cells (108) were cotransfected by electroporation with
linearized test plasmids and the linearized plasmid SV2neo which
carries a resistance gene to the antibiotic neomycin. To select for
stable transformants, cells were grown for 4-8 weeks in the
presence of 500 /vg/ml of the neomycin analog aminoglycoside
antibiotic G418.
Individual clones were isolated by limiting dilution
and cultured independently for an additional 4-8 weeks in the
presence of 250 /vg/ml of G418. Cell lysate from 108 cells of each
clone was prepared by repeatedly freezing and thawing three times
followed by incubation at 60° C for 10 min. Lysate was separated
from cell debris by centrifugation at 10,000 g for 5 min. The
protein concentration from each lysate was determined by the
Bradford method to normalize CAT activity from reaction to
reaction.
Stabile transformed U373-MG cells were prepared as above
with the exception that individual clones transfected with the same
constructs were pooled and lysates were prepared from the
resulting population of clones.
Chloramphenicol acetyl transferase (CAT) activity from each
lysate was determined by adding 50 /7l of lysate to a 150 /vl reaction
mixture containing 2.5 mM chloramphenicol, 5 /vl [Acetyl-1-14C]
acetyl Coenzyme A (specific activity = 0.010 mCi/ml) [Dupont, NEN]),
and 0.1 M Tris-HCI pH 7.4. This mixture was added to 5 ml of
Econolume liquid scintillation cocktail (ICN Biomedicals) and
incubated at 37° C. At 30, 60, and 120 min of incubation, the amount
of C14 transferred was determined by scintillation counting.
DMA was isolated from 108 cells of each clone by proteinase K
digestion (0.5 mg/ml) in 1% SDS at 50° C for 3 hr followed by
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phenol/chloroform extraction and ethanol precipitation. The DNA
(20 ijg) from each clone was digested with 100 u/ml of an
appropriate restriction endonuclease at 37° C for 10-14 hr. The DNA
was electrophoretically resolved on a 1.0% agarose gel and analyzed
by the Southern method.

RESULTS
To show the regulatory region of the MIE gene of HCMV contains
a S/MAR this fragment of DNA was tested to determine if it fulfilled
three biochemical criteria for S/MARs. The MIE regulatory region
was first tested for its capability to bind to the nuclear matrix
using an in vitro nuclear matrix binding assay. The in vitro nuclear
matrices for this assay were prepared by first isolating and
permeablizing nuclei by homogenizing uninfected Tera 2 embryonic
carcinoma cells in a hypotonic buffer containing Triton X-100. The
chromatin was removed by treatment with DNase I. The residual
nuclei were then extracted with 2 M NaCI. DNA fragments generated
by restriction digest of a DNA construct containing the test
fragment, were end-labeled by the Klenow DNA polymerase fragment
fill-in reaction, and added to the in vitro nuclear matrices. E coli
DNA was added to the reaction as a non-specific competitor. Bound
fragments were separated from non-bound fragments by low speed
centrifugation which pellets the bound fragments with the nuclear
matrices. The bound DNA was isolated from the nuclear matrices by
proteinase K digestion. The total counts per minute present in the
both supernatant and the pellet fractions were determined by
Cherenkov scintillation counting. Equal counts per minute from both
the supernatant and the pellet fractions for each reaction were
analyzed by electrophoresis.
Figure 2A is an EcoRI restriction map of the genome of the AD169
strain of HCMV. The MIE gene is composed of a 1.1 kb regulatory
region and a 6.0 kb coding region located within the 10.0 kb EcoRI
restriction fragment J. This fragment has been inserted into the
pBR322 derived vector pACYC184 to generate the plasmid pEcoRIJ.
Figure 3, lane 1 shows the fragments generated when this plasmid is
digested with the restriction endonuclease Ava I. Lanes 2-4 and 5-7
are the supernatant and pellet fractions respectively, from three
individual in vitro nuclear matrix binding reactions, each containing
a different concentration of non-specific competitor DNA. For each
individual reaction a comparison of the total counts per minute
38
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Figure 2. A) The EcoRI restriction endonuclease digestion map of the
AD169 strain of HCMV genome. B) restriction endonuclease
digestion maps of the 10038bp EcoRI J fragment. The arrow
indicates the start site and direction of transcription.
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Figure 3. In Vitro Nuclear Matrix Binding To Tera 2 Nuclear Matrices.
Nuclear matrices were prepared by 2 M NaCI extraction of nuclei
derived from human THP-1 leukemic monocytes. Nuclear matrices
were incubated with 5'-end labeled fragments generated by the Ava I
digestion of the plasmid containing the major immediate early gene.
The nuclear matrix bound fragments were separated from the
unbound fragments by low speed centrifugation. The bound
fragments fractionate with the pellet and the unbound fragments
fractionate with the supernatant. DNA isolated from E. coli was
added to the reactions as a non-specific competitor. The DNA
fragments within the supernatant and pellet fractions were analyzed
by electrophoresis through 1.0% agarose. Lanes 1 contains the input
fragments in the absence of nuclear matrices and non-specific
competitor. Lanes 2-4 contain unbound fragments from reactions
containing 0, 10, and 100 /vg/ml of non-specific competitor
respectively. Lanes 5-7 contain bound fragments from reactions
containing 0,10, and 100 /vg/ml of non-specific competitor
respectively.

42

INPUT

SUPERNATANT

PELLET

10

10

3077 mmm

100

100

<■

:

1962
1719
1466
1200
1119

'
:

726
S72
S02
47€
40S

>

43
present in the supernatant with the total counts per minute present
in the pellet showed that between 1% and 3% of the total labeled
fragments bound to the in vitro nuclear matrix. In a given reaction,
a comparison of the fragments present in the pellet fraction shows
the 1962 bp fragment, which contains the regulatory region of MIE
spanning (-) 1453 to (+) 509, binds the nuclear matrix with the
greatest affinity. The autoradiographic signal intensity generated
from each fragment in the pellet fraction in a random individual
reaction was determined by scanning densitometry and used to
calculate the relative affinities of each fragment for the nuclear
matrix. The 1962 bp fragment binds the nuclear matrix with a
4.3-fold greater affinity than the 1466 bp vector fragment and with
a 28-fold greater affinity than the 1200 bp MIE coding region
fragment.
To determine the location within the regulatory region which
contains the in vitro nuclear matrix binding capability, the pEcoRIJ
plasmid was digested with the restriction endonuclease Bsa HI
(Figure 2B). This enzyme cleaves the MIE regulatory region into four
fragments the largest being 822 bp spanning (-) 459 to (-) 1280.
The viral and vector fragments were reacted with nuclear matrices
prepared in vitro (Figure 4). Comparison of the fragments in the
pellet fraction of a given reaction shows the 822 bp fragment binds
the in vitro nuclear matrix with the highest affinity relative to the
other viral and vector fragments.
To define the region of the MIE gene containing the in vitro
nuclear matrix binding capability with greater precision, the
pEcoRIJ clone was double digested with the restriction
endonucleases Sau96 I and Pst I (Figure 2B). Together, these
enzymes cleave the regulatory region into a number of fragments the
largest being 646 bp spanning (-) 497 to (-) 1142 of the MIE gene.
This fragment contains the modulator as previously defined (Nelson
et al., 1987) but does not contain the enhancer of this gene. The
viral and vector fragments were reacted with nuclear matrices
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Figure 4. In Vitro Nuclear Matrix Binding To Tera 2 Nuclear Matrices.
Nuclear matrices were prepared by 2 M NaCI extraction of nuclei
derived from human THP-1 leukemic monocytes. Nuclear matrices
were incubated with 5'-end labeled fragments generated by the Bsa
HI digestion of the plasmid containing the major immediate early
gene. The nuclear matrix bound fragments were separated from the
unbound fragments by low speed centrifugation. The bound
fragments fractionate with the pellet and the unbound fragments
fractionate with the supernatant. DNA isolated from E. coli was
added to the reactions as a non-specific competitor. The DNA
fragments within the supernatant and pellet fractions were analyzed
by electrophoresis through 1.0% agarose. Lanes 1 contains the input
fragments in the absence of nuclear matrices and non-specific
competitor. Lanes 2-4 contain unbound fragments from reactions
containing 0, 10, and 100 /vg/ml of non-specific competitor
respectively. Lanes 5-7 contain bound fragments from reactions
containing 0,10, and 100 /yg/ml of non-specific competitor
respectively.
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prepared in vitro (Figure 5). The input DNA (lane 1) shows the
646 bp fragment labels with low efficiency relative to the other
fragments. Comparing the relative signal intensities of the
fragments in the pellet fraction of a given reaction shows the
646 bp fragment signal is equal to, or greater than, the signal
generated by any other fragment. This suggests that this fragment
binds the in vitro nuclear matrix with a greater affinity than the
other viral or vector DNA fragments.
Finally, the binding of the MIE regulatory region to the in vitro
nuclear matrix was tested relative to a well characterized MAR
contained within a 309 bp EcoRI fragment 5' of the human
immunoglobulin heavy chain enhancer (Cockerill and Garrard, 1987).
A 795 bp Pst l/Nde I fragment spanning (-) 1142 and (-) 347 of the
regulatory region of MIE, the 309 bp fragment of the human
immunoglobulin heavy chain enhancer, and a Xba l/EcoRI 2710 bp
fragment spanning 3920 to 2266 of the vector pCATBasic, were gel
purified and radioactively end labeled. These fragments were added
to in vitro nuclear matirices in the presence of increasing
concentrations of E. coli DNA and bound and non-bound fragments
were distinguished and analyzed as above (Figure 6). Both the
immunoglobulin heavy chain MAR and the MIE regulatory region
fragments bound the in vitro nuclear matrix. The vector fragment
did not bind the in vitro nuclear matrix. In total, these results
indicate the regulatory region of the MIE gene fulfills the in vitro
nuclear matrix binding criteria and is supporting evidence that this
region of the viral genome has the characteristics of a cellular
S/MAR.
The regulatory region of MIE was tested for its nuclear
scaffold binding capability in situ to determine whether it fulfilled
this criteria for a S/MAR. The Mirkovitch and Laemmli method of
mapping DNA sequences which interact with the nuclear scaffold,
was the chosen protocol for nuclear scaffold isolation for this assay
because LIS extraction of nuclei has been shown to not precipitate
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Figure 5. In Vitro Nuclear Matrix Binding To Tera 2 Nuclear Matrices.
Nuclear matrices were prepared by 2 M NaCI extraction of nuclei
derived from human THP-1 leukemic monocytes. Nuclear matrices
were incubated with 5'-end labeled fragments generated by the Pst
l/Sau 96I digestion of the plasmid pEcoRI J containing the major
immediate early gene. The nuclear matrix bound fragments were
separated from the unbound fragments by low speed centrifugation.
The bound fragments fractionate with the pellet and the unbound
fragments fractionate with the supernatant. DNA isolated from E.
coli was added to the reactions as a non-specific competitor. The
DNA fragments within the supernatant and pellet fractions were
analyzed by electrophoresis through 1.0% agarose. Lanes 1 contains
the input fragments in the absence of nuclear matrices and non
specific competitor. Lanes 2-4 contain unbound fragments from
reactions containing 0, 10, and 100 £/g/ml of non-specific
competitor respectively. Lanes 5-7 contain bound fragments from
reactions containing 0,10, and 100 /vg/ml of non-specific
competitor respectively.
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Figure 6. In Vitro Nuclear Matrix Binding To Tera 2 Nuclear Matrices.
Nuclear matrices were prepared by 2 M NaCI extraction of nuclei
derived from human THP-1 leukemic monocytes. Nuclear matrices
were incubated with purified and 5' end labeled DNA fragments.
These DNAs include the well characterized MAR contained within the
309 bp EcoRI fragment 5' of the human immunoglobulin heavy chain
enhancer, a 2710 bp random fragment present within the vector
pCATBasic, and an 800 bp Pst l/Nde I fragment from the regulatory
region of the MIE gene spanning (-) 1142 to (-) 347. The nuclear
matrix bound fragments were separated from the unbound fragments
by low speed centrifugation. The bound fragments fractionate with
the pellet and the unbound fragments fractionate with the
supernatant. DNA isolated from E. coli was added to the reactions
as a non-specific competitor. The DNA fragments within the
supernatant and pellet fractions were analyzed by electrophoresis
through 1.0% agarose. Lanes 1 contains the input fragments in the
absence of nuclear matrices and non-specific competitor. Lanes 2-4
contain unbound fragments from reactions containing 0, 10, and
100 /ig/ml of non-specific competitor respectively.
Lanes 5-7
contain bound fragments from reactions containing 0,10, and
100 /vqM11 of non-specific competitor respectively.
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transcription complexes (Mirkovitch et al., 1984, 1986, and 1988).
Nuclei were isolated from MRC5 human lung fibroblasts at a given
time post infection with the AD169 laboratory strain of HCMV.
Nuclei were heat stabilized at 37° for 30 minutes to insolubilize the
scaffold core filament structure. The nuclei were extracted with
LIS detergent and digested with an appropriate restriction
endonuclease. Nuclear scaffold bound DNA was separated from non
bound DNA by low speed centrifugation. In most experiments the
pellet fraction was re-extracted with 2 M NaCI to disrupt any
artifactual binding of DNA sequences to the in situ nuclear scaffold
which may occur during the restriction endonuclease digestion.
Between 80% and 95% of the total DNA distributed to the
supernatant fraction and 5% to 20% of the total DNA distributed to
the pellet fraction. Equal concentrations of the supernatant and the
pellet DNA were resolved by electrophoresis and analyzed by the
Southern technique.
The well characterized human interferon-B gene (HuIFN-B)
S/MAR was used as a positive control for the following in situ
binding assays. This S/MAR is contained within a 2.2 kb EcoRI
fragment at the 3' boundary of the 14 kb chromatin domain of this
gene, and has been shown to bind the nuclear matrix in vitro and the
nuclear scaffold in situ (Bode and Maass, 1988). Figure 7 shows the
Southern analysis of DNA isolated from the supernatant and pellet
fractions of extracted fibroblast nuclei that were digested with
EcoRI. The cells from which the nuclei were isolated had been
infected with HCMV for 24 hours. The 2.2 kb HuIFN-B EcoRI fragment
was used as a probe for hybridization. Assuming the efficiency of
DNA recovery was equal for the supernatant and the pellet, digestion
resulted in 92.5% of the total DNA fractionating to the supernatant.
Scanning densitometry measures a 5-fold greater signal intensity of
the 2.2 kb fragment in the pellet fraction relative to the supernatant
fraction. This suggests that 80% of the HuIFN-B S/MAR DNA is
associated with the nuclear scaffold while only 7.2% of the total
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Figure 7. In Situ Nuclear Scaffold Binding in HCMV Infected Human
MRC5 Lung Fibroblasts Early Post Infection. Fibroblasts were
infected with the AD169 strain of HCMV at a multiplicity of
infection of 0.5 for 24 hours and nuclei were isolated by
homogenization in a hypotonic buffer. The nuclei were extracted
with 25 mM LIS, digested with EcoRI, and nuclear scaffold bound DNA
was separated from non-bound DNA by low speed centrifugation.
DNA was isolated from both the supernatant and the pellet fractions.
Equal concentrations of supernatant and pellet DNA fragments were
resolved by electrophoresis through 1.0% agarose and transferred to
a nylon membrane. A 2200 bp radioactively labeled fragment
containing the human interferon-(3 SAR was used as a probe for
hybridization.

53

9420
6560
4360

2867
2320#. •
2030#

54
cellular DNA associates with the nuclear scaffold. This experiment
was repeated using Pst I to digest extracted nuclei which had been
infected with HCMV for 6 hours (Figure 8). Of the total DNA 80%
fractionated with the supernatant. The Pst I restriction
endonuclease cleaves outside the EcoRI restriction sites flanking
the 3' HuIFN-B S/MAR to generate a 6.5kb fragment containing this
S/MAR. The 2.2 kb HuIFN-B EcoRI fragment was used as a probe for
hybridization. Scanning densitometry measures a 2-fold greater
signal intensity of the 2.2 kb fragment in the pellet fraction relative
to the supernatant fraction. This suggests >65% of the HuIFN-B SAR
DNA, and only 20% of the total cellular DNA, is associated with the
nuclear scaffold. These results suggest this region of the cellular
genome associates with the nuclear scaffold and are consistent with
the results of Bode and Maas.
Since S/MARs are generally located within the regulatory or
intronic regions of genes, the human B-actin coding region was used
as a negative control for the in situ nuclear scaffold binding assay.
Digestion of this gene with the high cleavage frequency restriction
endonuclease Sau96 I generates primarily small fragments as well
as three larger fragments contained within exons, of 356, 577, and
605 bp. Figure 9 shows the Southern analysis of DNA isolated from
the supernatant and pellet fractions of extracted fibroblast nuclei
digested with Sau96 I. Fluman B-actin cDNA was used as a probe for
hybridization. The predicted fragments hybridize with the probe as
well as a fragment of approximately 800bp which may be due to a
fragment which spans an intron/exon junction. Densitometry of the
autoradiograph measures a 4.2-fold greater DNA concentration of the
B-actin coding region in the supernatant relative to the pellet
suggesting that this region of the cellular genome does not
associate with the nuclear matrix. This experiment was repeated
using Pst I to digest extracted nuclei which had been infected with
HCMV for 6 hours (Figure 10). This restriction endonuclease cleaves
once within the coding region of B-actin. Two of the fragments
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Figure 8. In Situ Nuclear Scaffold Binding in HCMV Infected Human
MRC5 Lung Fibroblasts at an Immediate Early Time Post Infection.
Fibroblasts were infected with the AD169 strain of HCMV at a
multiplicity of infection of 0.5 for 6 hours and nuclei were isolated
by homogenization in a hypotonic buffer. The nuclei were extracted
with 25 mM LIS, digested with Pst I, and nuclear scaffold bound DNA
was separated from non-bound DNA by low speed centrifugation.
DNA was isolated from both the supernatant and the pellet fractions.
Equal concentrations of supernatant and pellet DNA fragments were
resolved by electrophoresis through 1.0% agarose and transferred to
a nylon membrane. A 2200 bp radioactively labeled fragment
containing the human interferon-B SAR was used as a probe for
hybridization.
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Figure 9. In Situ Nuclear Scaffold Binding in HCMV Infected Human
MRC5 Lung Fibroblasts Early Post Infection. Fibroblasts were
infected with the AD169 strain of HCMV at a multiplicity of
infection of 0.5 for 24 hours and nuclei were isolated by
homogenization in a hypotonic buffer. The nuclei were extracted
with 25 mM LIS, digested with Sau96 I, and nuclear scaffold bound
DNA was separated from non-bound DNA by low speed centrifugation.
DNA was isolated from both the supernatant and the pellet fractions.
Equal concentrations of supernatant and pellet DNA fragments were
resolved by electrophoresis through 1.0% agarose and transferred to
a nylon membrane. A 2300 bp radioactively labeled B-actin cDNA
fragment was used as a probe for hybridization.
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Figure 10. In Situ Nuclear Scaffold Binding in HCMV Infected Human
MRC5 Lung Fibroblasts at an Immediate Early Time Post Infection.
Fibroblasts were infected with the AD169 strain of HCMV at a
multiplicity of infection of 0.5 for 6 hours and nuclei were isolated
by homogenization in a hypotonic buffer. The nuclei were extracted
with 25 mM LIS, digested with Pst I, and nuclear scaffold bound DNA
was separated from non-bound DNA by low speed centrifugation.
DNA was isolated from both the supernatant and the pellet fractions.
Equal concentrations of supernatant and pellet DNA fragments were
resolved by electrophoresis through 1.0% agarose and transferred to
a nylon membrane. A 2200 bp radioactively labeled B-actin cDNA
fragment was used as a probe for hybridization.
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within the G-actin coding region generated by Pst I span an
intron/exon junction however, most correspond to G-actin
pseudogene fragments which span exon/chromatin junctions which
are distributed throughout the genome. Comparison of the DNA
present within the supernatant and pellet fractions suggest there is
a significantly greater amount of the G-actin gene not bound to the
nuclear scaffold relative to the amount of the gene bound to the
nuclear scaffold. This is consistent with the previous experiment
using this probe and suggests this region of the cellular genome is a
valid negative control for this experiment. Taken together, the
results of the positive and negative control regions in the in situ
nuclear scaffold binding assay, suggest this assay produces
reproducible results.
The MIE region of the HCMV viral genome was tested for its
capability to associate with the nuclear scaffold in situ during
early times of infection to ensure all infecting genomes have had
sufficient time to reach the nucleus and equilibrate with the nuclear
scaffold. At this time the MIE gene is expressed (Thomsen et al.,
1984) and viral DNA synthesis is at one of its two highest levels
post infection (St Jeor and Hutt, 1977). Fibroblast nuclei isolated
24 hours post infection were extracted, digested with EcoRI, and
nuclear matrix bound and non-bound DNA were separated by
centrifugation.
Figure 11 is the Southern analysis of supernatant and pellet
DNA hybridized with the 10 kb AD169 EcoRI J fragment. Two
different signals result from hybridization with this probe, one
which appears greater than 9.4kb and one which appears to be
approximately 8kb, relative to the labeled size marker DNA. To
determine if the larger fragment represents partially digested HCMV
genome containing the MIE region, MRC5 cells were first infected
with the AD169 strain of HCMV for 24 hours. DNA was then isolated
and digested with EcoRI without prior LIS extraction.
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Figure 11. In Situ Nuclear Scaffold Binding in HCMV Infected Human
MRC5 Lung Fibrobsasts Early Post Infection. Fibroblasts were
infected with the AD169 strain of HCMV at a multiplicity of
infection of 0.5 for 24 hours and nuclei were isolated by
homogenization in a hypotonic buffer. The nuclei were extracted
with 25 mM LIS, digested with EcoRI, and nuclear scaffold bound DNA
was separated from non-bound DNA by low speed centrifugation.
DNA was isolated from both the supernatant and the pellet fractions.
Equal concentrations of supernatant and pellet DNA fragments were
resolved by electrophoresis through 1.0% agarose and transferred to
a nylon membrane. A 10038 bp radioactively labeled AD169/EcoRI J
fragment was used as a probe for hybridization.

63

64
This DNA was hybridized with the EcoRI J fragment in a Southern
analysis (Figure 12). There is one major fragment of DNA which
hybridizes to the probe and several fragments which hybridize
weakly. The major fragment of DNA is approximately 8 kb and a
fragment of >9.4 kb hybridizes to a much lesser extent. This
suggests the 8 kb fragment is the EcoRI J fragment running
anomolously and the >9.4 kb fragment is undigested HCMV genome
which contains the MIE region.
Whatever the explanation for two differently sized DNA
fragments hybridizing with the EcoRI probe in figure 11, the high
stringency of the hybridization and filter washing suggest the two
fragments contain the MIE gene sequence. Virtually all of the probe
that hybridized did so to DNA in the pellet fraction suggesting that
100% of the MIE gene is bound to the nuclear scaffold at early times
of infection. This is significant because only 7.5% of the total
cellular DNA remained associated with the nuclear scaffold in this
experiment. This result suggests the HCMV viral genome associates
with the nuclear scaffold and that a region within the 10 kb EcoRI J
fragment fulfills the in situ nuclear scaffold binding criteria for
S/MARs.
Regions other than the MIE region of the HCMV genome were
tested for their capability to bind to the nuclear scaffold using the
in situ nuclear scaffold binding assay at early times of infection.
Since the EBV and adenovirus SARs contain dA ■ dT rich origins of
replication (Jankelevich et al., 1992; Schaack et al., 1990), the HCMV
lytic origin of replication was chosen as a test region for nuclear
scaffold association. This HCMV replication origin is contained
within the 4210 bp EcoRI fragment U of the genome (Figure 2A).
Figure 13 is the result of stripping the Southern membrane in
Figure 11 of EcoRI J probe and rehybridizing with labeled EcoRI U
fragment. There are a number DNA fragment sizes generating
radioactive signal. One fragment is >9.4 kb and another fragment is
approximately 8.0 kb. These are most likely due to residual EcoRI J
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Figure 12. Southern analysis of HCMV Infected Human MRC5 Lung
Fibroblasts Early Post Infection. Fibroblasts were infected with the
AD169 strain of HCMV at a multiplicity of infection of 0.5 for 24
hours. The cells were proteinase K digested and DMA was isolated by
ethanol precipitation. The DMA was digested by EcoRI at 37° C for
12 hours. DMA fragments were resolved by electrophoresis through
1.0% agarose and transferred to a nylon membrane. A 10038 bp
radioactively labeled AD169/EcoRI J fragment was used as a probe
for hybridization.
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Figure 13. In Situ Nuclear Scaffold Binding in HCMV Infected Human
MRC5 Lung Fibroblasts Early Post Infection. Fibroblasts were
infected with the AD169 strain of HCMV at a multiplicity of
infection of 0.5 for 24 hours and nuclei were isolated by
homogenization in a hypotonic buffer. The nuclei were extracted
with 25 mM LIS, digested with EcoRI, and nuclear scaffold bound DMA
was separated from non-bound DNA by low speed centrifugation.
DNA was isolated from both the supernatant and the pellet fractions.
Equal concentrations of supernatant and pellet DNA fragments were
resolved by electrophoresis through 1.0% agarose and transferred to
a nylon membrane. A 4210 bp radioactively labeled AD169/EcoRI U
fragment was used as a probe for hybridization.
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probe which did not wash away during the stripping procedure. A
third band is approximately 4.2 kb which is the predicted size of the
EcoRI U fragment. Densitometric analysis of the 4.2 kb fragment
measures a 3-fold greater signal from the bound fraction relative to
the non-bound fraction. Again, this is significant since 92.5% of the
total cellular DNA fractionated with the supernatant while 75% of
the EcoRI U region of HCMV associates with the nuclear scaffold.
Since the majority of S/MARs characterized to date are, with a
few exceptions, dA • dT rich, it was predicted that a dG ■ dC rich
region of the viral genome would not associate with the nuclear
scaffold in situ. The 4060 bp EcoRI V region (Figure 2A) is 60% GC
rich and was chosen as a viral negative control for nuclear scaffold
binding in situ.. Figure 14 is the rehybridization of the probe
stripped Southern membrane of Figure 11 with radioactive EcoRI V
fragment. This probe hybridizes with two different sized DNA
fragments; one which is greater than 9.4 kb and one which is
approximately 4 kb. The greater than 9.4 kb fragment maybe
partially digested HCMV genome which contains the EcoRI V region.
The smaller fragment is the predicted size of EcoRI V.
Densitometric analysis of the 4 kb fragment measures a 2-fold
greater signal present in the pellet fraction relative to the
supernatant fraction. Again, this is significant because 92% of the
total cellular DNA fractionated with the supernatant while >65% of
EcoRI V region associates with the nuclear scaffold. This is
contradictory to the predicted result since EcoRI V is dG ■ dC rich,
however it is consistent with the previous results suggesting the
HCMV genome associates with the nuclear scaffold at early times of
infection.
The MIE region was next tested for its capability to bind to the
nuclear scaffold using an in situ nuclear scaffold binding assay at
immediate early times of infection. At this time the majority of the
infecting genomes have been transported to the nucleus, the MIE gene
is expressed at its highest level, and little or no viral DNA synthesis
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Figure 14. In Situ Nuclear Scaffold Binding in HCMV Infected Human
MRC5 Lung Fibroblasts Early Post Infection. Fibroblasts were
infected with the AD169 strain of HCMV at a multiplicity of
infection of 0.5 for 24 hours and nuclei were isolated by
homogenization in a hypotonic buffer. The nuclei were extracted
with 25 mM LIS, digested with EcoRI, and nuclear scaffold bound DNA
was separated from non-bound DNA by low speed centrifugation.
DNA was isolated from both the supernatant and the pellet fractions.
Equal concentrations of supernatant and pellet DNA fragments were
resolved by electrophoresis through 1.0% agarose and transferred to
a nylon membrane. A 4060 bp radioactively labeled AD169/EcoRI V
fragment was used as a probe for hybridization.
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has been initiated. Fibroblast nuclei isolated 6 hours post infection
were extracted, digested with Pst I, and nuclear scaffold bound and
non-bound DNA were separated by centrifugation. To prevent viral
DNA synthesis, the cells were treated with the translation inhibitor
anisomysin just prior to and during infection. This ensures that no
viral early gene protein necessary for viral DNA synthesis could be
produced. To prevent the non-specific binding of large fragments
during the restriction endonuclease reaction, the digested nuclear
scaffold/DNA complexes were extracted with 2 M NaCI. Figure 15 is
the Southern analysis of supernatant and pellet DNA hybridized with
a 544 bp Pst l/Hinc II fragment spanning (-) 1142 and (-) 599 of the
Densitometric analysis measures a 3.6-fold higher signal
MIE gene.
generated from the pellet fraction relative to the supernatant
fraction. This suggests that at immediate early times of infection
the HCMV genome associates with the nuclear scaffold via the
regulatory region of MIE. It is also consistent with previous results
that the MIE regulatory region fulfills the in situ nuclear matrix
binding criteria for S/MARs.
To determine if the entire MIE region associates with the
nuclear scaffold at immediate early times of infection, the above
experiment was repeated with the exception that the EcoRI J
fragment was used as a probe for hybridization during the Southern
analysis (Figure 16). Pst I restriction endonuclease digestion of the
EcoRI J region generates four fragments (Figure 1B); a 4437 bp
fragment, which spans approximately 65% of the coding region of
MIE; a 2085 bp fragment, which contains the regulatory region; a
1467 bp fragment and a 629 bp fragment both of which are present
in the coding region. Densitometric analysis of the regulatory region
shows the signal from pellet fraction is 2-fold greater than the
signal from the supernatant fraction. This is consistent with
previous results suggesting the regulatory region binds to the
nuclear scaffold at immediate early times of infection. The signal
from the 4437 bp region within the coding region showed a 1.5-fold
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Figure 15. In Situ Nuclear Scaffold Binding in HCMV Infected Human
MRC5 Lung Fibroblasts at an Immediate Early Time Post Infection.
Fibroblasts were infected with the AD169 strain of HCMV at a
multiplicity of infection of 0.5 for 6 hours in the presence of
100 ji/M anisomycin and nuclei were isolated by homogenization in a
hypotonic buffer. The nuclei were extracted with 25 mM LIS,
digested with Pst I, and nuclear scaffold bound DNA was separated
from non-bound DNA by low speed centrifugation. DNA was isolated
from both the supernatant and the pellet fractions. Equal
concentrations of supernatant and pellet DNA fragments were
resolved by electrophoresis through 1.0% agarose and transferred to
a nylon membrane. A 544 bp Pst l/Hinc II fragment spanning
(-) 1142 to (-) 599 of the MIE regulatory region was radioactively
labeled and used as a probe for hybridization.
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Figure 16. In Situ Nuclear Scaffold Binding in HCMV Infected Human
MRC5 Lung Fibroblasts at an Immediate Early Time Post Infection.
Fibroblasts were infected with the AD169 strain of HCMV at a
multiplicity of infection of 0.5 for 6 hours in the presence of
100 jl/M anisomycin and nuclei were isolated by homogenization in a
hypotonic buffer. The nuclei were extracted with 25 mM LIS,
digested with Pst I, and nuclear scaffold bound DNA was separated
from non-bound DNA by low speed centrifugation. DNA was isolated
from both the supernatant and the pellet fractions. Equal
concentrations of supernatant and pellet DNA fragments were
resolved by electrophoresis through 1.0% agarose and transferred to
a nylon membrane. A 10038 bp radioactively labeled AD169/EcoRI J
fragment was used as a probe for hybridization.
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more intense signal relative to the signal from the supernatant.
This suggests this region of the MIE gene also binds the nuclear
scaffold at immediate early times of infection. The 1467 bp and
629 bp regions do not appear to bind to the nuclear scaffold.
The EcoRI V region of the genome was then analyzed for
nuclear scaffold association at immediate early times of infection.
Fibroblast nuclei isolated 6 hours post infection were extracted,
digested with Pst I, and nuclear scaffold bound and non-bound DNA
were separated by centrifugation (Figure 17). Pst I restricts the
EcoRI V region into two fragments one of which is 3838 bp and the
other of which is 570 bp. Densitometric analysis measures an
approximately equal signal from both fractions for the larger
fragment suggesting this region has some affinity for the nuclear
scaffold. The smaller fragment does not bind to the nuclear
scaffold.
To determine if the above results could be reproduced using an
alternative approach to the in situ nuclear scaffold binding assay,
nuclei from fibroblasts infected for immediate early times, were
extracted with LIS, digested with DNase I, and re-extracted with 2 M
NaCI. This removed >95% of the total DNA from the nucleus. The
remaining <5% of total in situ nuclear scaffold associated DNA was
isolated by proteinase K digestion of the residual nucleus and
radiolabeled. The radiolabeled DNA was used as a probe to hybridize
with a panel of viral EcoRI fragments representing different regions
of the HCMV genome (Figure 18). A comparison of the signals
generated by the various fragments by densitometric analysis
suggests that there is a wide range of specificity among the
fragments for nuclear scaffold binding in situ. The viral fragments
J, U, and Y (Figure 2A) bound the nuclear scaffold with a high
affinity relative to the other fragments. The viral fragments V and
Z bound with slightly lower affinity and the fragment E did not bind.
These results are consistent with previous results and suggest the
HCMV genome associates with the nuclear scaffold and that the
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Figure 17. In Situ Nuclear Scaffold Binding in HCMV Infected Human
MRC5 Lung Fibroblasts at an Immediate Early Time Post Infection.
Fibroblasts were infected with the AD169 strain of HCMV at a
multiplicity of infection of 0.5 for 6 hours in the presence of
100 /vM anisomycin and nuclei were isolated by homogenization in a
hypotonic buffer. The nuclei were extracted with 25 mM LIS,
digested with Pst I, and nuclear scaffold bound DNA was separated
from non-bound DNA by low speed centrifugation. DNA was isolated
from both the supernatant and the pellet fractions. Equal
concentrations of supernatant and pellet DNA fragments were
resolved by electrophoresis through 1.0% agarose and transferred to
a nylon membrane. A 4060 bp radioactively labeled AD169/EcoRI V
fragment was used as a probe for hybridization.
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Figure 18. In Situ Nuclear Scaffold Binding in HCMV Infected Human
MRC5 Lung Fibroblasts at an Immediate Early Time Post Infection.
Fibroblasts were infected with the AD169 strain of HCMV at a
multiplicity of infection of 0.5 for 6 hours in the presence of
100 /vM anisomycin and nuclei were isolated by homogenization in a
hypotonic buffer. The nuclei were extracted with 25 mM LIS,
digested with DNase I, and nuclear scaffold bound DNA was
separated from non-bound DNA by low speed centrifugation. DNA
was isolated from the pellet fraction. Equal concentrations of a
panel of AD169 genomic DNA fragments were resolved by
electrophoresis through 1.0% agarose and transferred to a nylon
membrane. The pellet DNA was radioactively labeled and used as a
probe for hybridization.
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regulatory region of MIE fulfills this criteria for a S/MAR. In
addition, other regions of the viral genome bind to the in situ
nuclear scaffold.
To determine if the regulatory region of MIE fulfilled a third
criteria for a S/MAR, the 543 bp dA • dT rich region spanning
(-) 1142 bp to (-) 599 bp of MIE was tested for its transcription
regulating capability in stabile transformed cells. This region
showed nuclear matrix binding in the in vitro binding assay.
Transient transfection studies have shown this region has a
repressing activity in non-permissive cells and an activating
activity in permissive cells (Nelson et al., 1987; Huang et al., 1996).
The leukemic monocyte THP-1 is non-permissive to HCMV infection
however becomes permissive after the cells are induced to
differentiate into macrophage-like cells by treatment with
12-0-tetradecanoyl-phorbol-13-acetate (TRA).
Two DNA constructs
were used to transfect THP-1 cells. The first construct, named
pPXCAT, contained a full length MIE regulatory region spanning
(-) 1142 to (+) 75 bp fused to a chloramphenicol acetyl transferase
reporter gene. The second construct, named pHXCAT, contained the
regulatory region of MIE, with a deletion of the 543 bp dA ■ dT rich
region, fused to a chloramphenicol acetyl transferase reporter gene.
These were linearized and separately cotransfected at a 10-fold
excess with a linearized construct containing the neomycin
resistance gene, into THP-1 by electroporation. Stable
transformants were selected by culturing the transfected cells in
the presence of G418 for four weeks. Single cells were isolated by
limiting dilution and grown to high titers to produce several clones.
The presence and number of integrated copies of the MIE regulatory
region construct was determined for each clone by Southern
analysis. Figure 19 is the Southern analysis of DNA isolated from
12 clones which were transfected with pHXCAT. The DNA was
digested with EcoRI which cleaves at two sites within the
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Figure 19. Southern Analysis of Stabile Transformed THP-1
Monocyte Clones. The MIE regulatory region from which the sequence
spanning (-) 1142 to (-) 599 was deleted, was inserted upstream of
a CAT reporter gene and cotransfected with a construct conferring
neomycin resistance, into the THP-1 monocyte. Stabile transformed
cells were selected by culturing in the presence of G418 and
individual clones were isolated by limiting dilution. DNA was
isolated from each clone and digested with the restriction
endonuclease EcoRI. The restriction fragments were resolved by
electrophoresis and transferred to a nylon membrane. The DNA
construct used for transfection was radioactively labeled and used
as a probe for hybridization.
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integrated construct to generate a product of 3644 bp and a product
of 1392 bp. The linearized construct used for transfection was
radiolabeled and used as a probe for hybridization. The equivalent of
one tenth, one, and ten copies per cell of the construct digested with
EcoRI was loaded onto the gel to serve as a standard for quantitating
the number of integrated constructs per clone. Four of twelve
clones, or 33% of the total clones containing an integrated neomycin
expressing construct, contain integrated copies of the MIE construct.
Densitometric analysis of the signals from the positive clones and
the signals from the standards, measures the positive clones contain
between 5 and 10 integrated copies of the MIE construct. Figure 20
is the Southern analysis of DNA isolated from 13 clones which were
transfected with pPXCAT. The DNA was digested with EcoRI which
cleaves at two sites within the integrated construct to generate a
product of 4182 bp and a product of 1392 bp. Three out of thirteen
clones, or 23% of the clones containing an integrated neomycin
expressing construct, contain integrated copies of the MIE construct.
Densitometric analysis of the signals from the positive clones and
the signals from the standards, measures the positive clones contain
between 1 and 5 integrated copies of the MIE construct.
One half of the cells of each individual positive clone was
treated with TPA to induce differentiation and undifferentiated and
differentiated clones were analyzed for chloramphenicol acetyl
transferase (CAT) activity. The protein concentration of each
sample used for the CAT analysis was determined by the Bradford
method. CAT activities for each clone were normalized to protein
concentration and to the number of construct copies integrated.
Figure 21 is a comparison of the CAT activities of the three
undifferentiated cellular clones containing the full length regulatory
region construct and the four undifferentiated cellular clones
containing the regulatory region deletion construct. When the CAT
values from the full length construct clones are averaged and
compared with the average of the CAT values from the deletion
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Figure 20. Southern Analysis of Stabile Transformed THP-1
Monocyte Clones. THP-1 Monocytes were cotranfected with a DNA
construct containing the full length MIE regulatory region inserted
upstream of a CAT reporter gene, and a construct conferring
neomycin resistance. Stabile transformed cells were selected by
culturing in the presence of G418 and individual clones were
isolated by limiting dilution. DNA was isolated from each clone and
digested with the restriction endonuclease EcoRI. The restriction
fragments were resolved by electrophoresis and transferred to a
nylon membrane. The DNA construct used for transfection was
radioactively labeled and used as a probe for hybridization.
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Figure 21. The chloramphenicol acetyl transferase activities of
stabile transformed THP-1 clones normalized to protein
concentration and to number of copies of integrated plasmid.
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construct clones the full length clones show a 3.4-fold higher
activity. Figure
22 is a comparison of the CAT activities of the
three TPA differentiated cellular clones containing the full length
regulatory region construct and the four TPA differentiated cellular
clones containing the regulatory region deletion contsruct. When the
CAT values from the full length construct clones are averaged and
compared with the average of the CAT values from the deletion
construct clones the full length clones show a 5.3-fold higher
activity. Although there is not enough clones to make a statistically
valid conclusion, these results suggest the deleted region has a
transcription activating function in both undifferentiated and in
differentiated THP-1 cells.
To provide further evidence that the deleted region spanning
(-) 1142 to (-) 599 bp of the MIE gene has a transcription activating
function, stabile transformed populations of cells were analyzed for
CAT expression levels. The human astrocytoma cell line U373-MG is
permissive for HCMV multiplication and was transfected separately
with pPXCAT and pHXCAT. A construct conferring neomycin
resistance was cotransfected with both constructs into their
respective cell populations. Stable transformants were selected by
growing the cells in the presence of a high concentration of G418 for
5 weeks to produce colonies of individual clones. The antibiotic
concentration was reduced 2-fold and the colonies were grown for
an additional 4 weeks. Figure 23 shows the CAT activities of
lysates from respectively pooled colonies from the two different
types of transformant normalized to protein concentration. A
comparison of the CAT expression levels shows a 9-fold increase in
CAT activity from the cells transfected with the full length
construct relative to the cells transfected with the deletion
construct.
In total, the results of the stable transformation
experiments suggest the region spanning (-) 1142 to (-) 599 bp of
the MIE gene has a transcription activating function and therefore
fulfills this criteria of a S/MAR.
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Figure 22. The chloramphenicol acetyl transferase activities of
stabile transformed and TPA treated THP-1 clones normalized to
protein concentration and to number of copies of integrated plasmid.
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Figure 23. The CAT activities of stabile transformed U373-MG
astrocytoma cells normalized to protein concentration. U373-MG
astrocytoma cells were cotranfected with a DNA construct
containing the full length MIE regulatory region inserted upstream of
a CAT reporter gene, and a construct conferring neomycin resistance.
A second population of U373-MG cells were cotranfected with a DNA
construct containing a deletion spanning (-) 1142 to (-) 599 within
the MIE regulatory region, and the neomycin gene. Stabile
transformed cells were selected by culturing in the presence of
G418 for 5 weeks resulting in colonies of individual clones. The
colonies from a given type of transformant were pooled and the
protein concentration and CAT activity of the lysate from each pool
was determined.
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To provide further evidence that the regulatory region of MIE is
a S/MAR, the stable transformant clones containing pPXCAT and
pHXCAT integrated into their respective cellular chromosomes, were
analyzed for their capability to bind the nuclear scaffold in an in
situ nuclear scaffold binding assay. The nuclei from each type of
clone were extracted with LIS and digested with Bam HI. The nuclear
scaffold bound DNA was separated from the non-bound DMA by
centrifugation and analyzed by Southern analysis. Figure 24 shows
both fractions of DNA isolated from extracted and digested nuclei
containing the integrated full length regulatory region. The
supernatant contained 80% of the total DNA and the pellet contained
20% of the total DNA. Densitometric analysis measures a 1.5-fold
higher signal generated from the pellet fraction relative to the
supernatant fraction suggesting the MIE regulatory region binds to
the in situ nuclear scaffold when integrated into the cellular
genome. Figure 25 is the Southern analysis of supernatant and pellet
fractions of DNA isolated after centrifugation of extracted and
EcoRI digested nuclei containing the integrated pHXCAT. The pHXCAT
construct was used as a probe for hybridization. Of the total DNA,
85% fractionated with the supernatant and 15% fractionated with
the pellet. EcoRI cleavage of pHXCAT generates a product of
3644 bp. The major hybridization signal is an approximately 3.6 kb
fragment present exclusively in the supernatant fraction, suggesting
the dA • dT rich region is required for nuclear scaffold binding in
situ. These results are consistent with previous results and are
further evidence the regulatory region of MIE contains a S/MAR.
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Figure 24. In Situ Nuclear Scaffold Binding in Stabile Transformed
THP-1 Monocytes. Monocytes were cotransfected with a construct
containing the full length 5' regulatory region of MIE and a construct
expressing the neomycin resistance gene. Stabile transformed cells
were selected by growing the cells in the presence of G418 for
4 weeks. Nuclei were isolated by homogenization in a hypotonic
buffer, extracted with 25 mM LIS, and digested with EcoRI. Nuclear
scaffold bound DNA was separated from non-bound DNA by low speed
centrifugation. DNA was isolated from both the supernatant and the
pellet fractions. Equal concentrations of supernatant and pellet DNA
fragments were resolved by electrophoresis through 1.0% agarose
and transferred to a nylon membrane. The full length 5' regulatory
region of MIE was used as a probe for hybridization.
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Figure 25. In Situ Nuclear Scaffold Binding in Stabile Transformed
THP-1 Monocytes. Monocytes were cotransfected with a construct
containing a partial deletion of the 5' regulatory region of MIE and a
construct expressing the neomycin resistance gene. Stabile
transformed cells were selected by growing the cells in the
presence of G418 for 4 weeks. Nuclei were isolated by
homogenization in a hypotonic buffer, extracted with 25 mM LIS, and
digested with EcoRI. Nuclear scaffold bound DNA was separated
from non-bound DNA by low speed centrifugation. DNA was isolated
from both the supernatant and the pellet fractions. Equal
concentrations of supernatant and pellet DNA fragments were
resolved by electrophoresis through 1.0% agarose and transferred to
a nylon membrane. The partially deleted 5' regulatory region of MIE
was used as a probe for hybridization.
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DISCUSSION
The periodic attachment of the eukaryotic cellular genome to
the nuclear matrix/scaffold resulting in loop domain structures is
the highest level of chromatin organization and could conceivably
provide a mechanism by which the expression and replication of the
genome can be regulated as a whole. When analyzed in total, the
regions of DNA which associate with the nuclear matrix/scaffold
demonstrate a wide range of characteristics. These
characteristics include: 1) binding to the nuclear matrix in an in
vitro nuclear matrix binding assay; 2) binding to the nuclear
scaffold in an in situ nuclear scaffold binding assay; and
3) activating transcription in stabile transformed cell types. This
study was undertaken to determine whether the HCMV genome,
which does not integrate into the infected host chromosome, is
organized into loop structures by association with the nuclear
scaffold/matrix. The regulatory region of the MIE gene has a
number of sequence characteristics of a S/MAR and was therefore
chosen as a test region for nuclear scaffold/matrix association as
defined by the above characteristics.
The regulatory region of MIE was first tested to determine
whether it binds to the nuclear matrix in vitro. The results
presented here show conclusively that the regulatory region of MIE
contains a MAR. This MAR has been precisely defined to a 646 bp
region spanning (-) 497 to (-) 1142 bp of this gene. The binding of
this and other MARs to the in vitro nuclear matrix cannot be
competed for by a large excess of double-stranded bacterial DNA.
This suggests that MAR elements are a unique characteristic of
eukaryotic DNA and is further evidence that the binding of the
nuclear matrix to a MAR is DNA sequence specific.
The regulatory region of MIE was then tested to determine
whether it binds to nuclear scaffold in situ. In total, the results
indicate the MIE regulatory region does bind to the nuclear scaffold
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of the infected cell nucleus relative to 80-95% of the total cellular
DNA and can therefore be defined as a SAR.
Two different signals result from the hybridization of the
EcoRI J probe with EcoRI digested DNA isolated from cells extracted
at early times post infection. It is possible the two bands represent
two different conformations of the predicted 10 kb fragment. The
regulatory region of MIE has been shown to form single stranded
non-B DNA structures in situ (Kowhi-Shigematsu and Nelson, 1988).
This may increase the mobility of the DNA during electrophoretic
resolution. If in a population of 10 kb molecules a fraction assume
this structure and the remaining fraction does not, then two
differently migrating molecules would result.
Alternatively, the dA
■ dT richness of the fragment may result in a relatively narrow
minor groove. DNA regions which contain a narrow minor groove
have been shown to cause DNA to bend (Nelson et al., 1987). This
bending in a subpopulation of molecules may cause a portion of them
to migrate anomolously through the agarose gel during
electrophoresis. Another possible explanation is the smaller
fragment may be the result of EcoRI star activity. Although the
restriction endonuclease digestion was under optimal conditions, as
determined by the manufacturer, there are 15 predicted EcoRI star
sites contained within the EcoRI J region. Finally, it has been shown
that LIS detergent inhibits the complete digestion of DNA by
restriction endonucleases. It is therefore possible the larger
fragment represents partially digested HCMV genome containing part
or all of the MIE region, and the smaller fragment represents the
EcoRI J fragment which migrates with an increased mobility for one
or more of the reasons outlined above. The hybridization of the
EcoRI J probe to a fragment of 8.0 kb in the Southern analysis of DNA
isolated from cells which have been infected but not extracted, as in
figure 12, is evidence supporting this last possibility.
There are at least three interpretations of the results of the
in situ nuclear scaffold binding assays of cells infected with HCMV
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for 24 hours. One possibility is that the HCMV genome associates
directly with the in situ nuclear scaffold at early times of infection
through at least three attachment regions along the viral genome;
the EcoRI J, U, and V regions. A second possibility is the viral
genome is being replicated at this time post infection and is
therefore transiently associated with replication complexes. These
complexes may be co-precipitating with the nuclear scaffold during
extraction and therefore the interaction between the HCMV genome
and the in situ nuclear scaffold at early times of infection may be
due to replicating HCMV genomes associated with cellular/viral
replication machinery. It is known that in high salt extracted
nuclei, and in nuclei which have been extracted by the Cook protocol,
cellular replication complexes are associated with the in situ
nuclear matrix/scaffold (Tubo et al., 1987; Hozak et al., 1993). It
has also been shown for HSV-1 that at early times of infection the
viral genome and viral replication proteins are associated with sites
of cellular DMA synthesis (Quinlan et al, 1984; de Bruyn Kops and
Knipe, 1994). Although it is well documented LIS extraction of
nuclei does not coprecipitate transcription complexes (Mirkovitch et
al., 1984, 1986, and 1988), there are no published accounts
regarding a determination whether LIS extraction of nuclei
precipitates replication complexes.
A third interpretation is that non-specific binding of one or
more of the viral genomic regions occurs during the restriction
endonuclease digestion portion of the extraction protocol. Although
most authors who use the LIS extraction method to map regions of
DMA which associate with the in situ nuclear scaffold do not address
this possibility, this can occur because the digestion conditions (i.e.
salt concentration, pH, and temperature) are similar to the
conditions of the in vitro nuclear matrix binding assay. The in vitro
assay does not discriminate between MAR fragment binding and
non-specific binding of large fragments (>4 kb). The binding of the
large fragments of HCMV genome (i.e. EcoRI fragments V, I, U, and J)
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may therefore be artifactual. It has been shown that nuclear
matrix/DNA binding in vitro is inhibited by 2 M NaCI extraction
independent of the size and sequence of the DNA (Vassetzky et al.,
1989). The binding of DNA to the matrix in situ (i.e. true
SAR/matrix association) is not inhibited by 2 M NaCI extraction.
The in situ binding assays done at immediate early times post
infection eliminate the potential artefacts of the assays done at
early times post infection. The results suggest the HCMV genome
interacts with the in situ nuclear scaffold through at least two
regions of the viral genome at immediate early times of infection;
the EcoRI J and V regions. At 6 hours post infection the MIE gene is
expressed however no viral replication occurs. Therefore, the
associations are not due to transient interactions with the nuclear
scaffold through replication or transcription complexes and are not
due to non-specific binding occurring during the restriction
endonuclease digestion.
There is a selective enrichment of a number of regions of the
HCMV genome within the nuclear scaffold fraction and these also
may be defined as SARs. This suggests the HCMV genome makes
multiple associations with the nuclear scaffold along its length. It
is beyond the scope of this project to determine if the regions
outside the MIE regulatory region contain sequences which fulfill the
other criteria for S/MARs as well, however this would be an
informative direction to continue research in. What can be
concluded from this study is the viral genome/nuclear
matrix/scaffold association does not organize the HCMV genome into
a single large cellular chromatin loop-like structure. The nuclear
matrix/scaffold organizes the HCMV genome into a number of
relatively small loops. By comparison, it has been proposed the
genomes of other large non-integrating DNA viruses such as EBV and
adenovirus form single loop domains via a single specific site of the
genomes associating with the nuclear matrix/scaffold.
A critical
analysis of the published data however, shows that all regions of
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each of these genomes associate with the nuclear scaffold/matrix
with some affinity relative to the majority of cellular DNA. The
actual results of these studies are not unlike the results of this
study and are subject to interpretation.
*
Finally, the regulatory region of MIE was tested to determine
whether it activates transcription in stabile transformed cells.
This study shows that in both stabile transformed cellular clones
and in a population of stabile transformed cells, the regulatory
region spanning (-) 1142 bp to (-) 599 activates transcription of an
associated reporter gene. It is possible the stable integration of the
S/MAR containing gene activates transcription via a desuppression
of an otherwise suppressed gene by allowing for the maintanace of
an unpaired region of DNA.
It has been proposed that S/MAR elements act to organize the
cellular genome genome into distinct transcription units. A
chromatin fractionation and micrococcal nuclease digestion analysis
of the active chicken lysozyme gene in chicken oviduct cells has
determined this chromatin domain to be19 kb (Stratling et al.,
1986). A similar analysis of the active human interferon-6 gene in
fibroblasts (Bode et al., 1986) and the active human apolipoprotein B
gene in liver cells (Levy-Wilson and Fortier) has determined these
chromatin domains to be 14 kb and 47.5 kb respectively. All of these
genes are flanked by S/MARs at the 5' and 3' boundaries defined by
the hypersensitivity analyses. If the S/MARs at the boundaries of
these genes lie at the base of a chromatin loop, this could be a
mechanism by which the activity of one of the genes would not be
influenced by the activity of other genes. The insulating effect of
S/MARs would provide the cell with a means of limiting the effects
of cis-acting regulatory elements to the genes they are associated
with thereby providing a mechanism to "globally" control
transcription of the genome as a whole. S/MARs contained within
the genomes of large DNA viruses which do not integrate into the
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host genome upon infection may also act to insulate viral cis-acting
regulatory elements from genes outside of their jurisdiction.
Relative to the human cellular genome viral genomes are 103
to 104-fold smaller and the ratio of open reading frames per unit
length of DNA is approximately 25-fold larger. The close
association of genes present within the viral genome may
necessitate multiple associations of the genome with the in vivo
scaffold/matrix/skeleton. This would result in a reduced average
loop size relative to the cellular chromatin loop size. For example,
the human genome is 3 X 109 bp and contains approximately 105
genes. The ratio of the number of genes to the size of the genome, or
gene density, is therefore 3.36 X 10*5 genes/bp. The HCMV genome is
2.4 X 105 and contains 208 genes and its gene density is 8.66 X 10'4
genes/bp. The HCMV genome has a 26-fold greater gene density than
the human cellular genome. The average loop size of the cellular
genome is 105 bp which correlates with 3.33 genes/loop. If there is
a concomitant decrease in loop size with an increase in gene density
then the average loop size of the HCMV genome should be 26 times
smaller than the cellular loop size or 3.8 X 103 bp.
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